Table of Contents
false--12-31Q30001843714 0001843714 2023-01-01 2023-09-30 0001843714 2022-01-01 2022-09-30 0001843714 2023-09-30 0001843714 2022-12-31 0001843714 2023-07-01 2023-09-30 0001843714 2022-07-01 2022-09-30 0001843714 2023-04-01 2023-06-30 0001843714 2023-01-01 2023-03-31 0001843714 2022-01-01 2022-03-31 0001843714 2022-04-01 2022-06-30 0001843714 2022-01-18 2022-01-18 0001843714 2023-07-14 2023-07-14 0001843714 2023-07-14 0001843714 2021-12-31 0001843714 2022-09-30 0001843714 2022-03-31 0001843714 2022-06-30 0001843714 2023-06-30 0001843714 2023-03-31 0001843714 wnnr:MarketableSecuritiesHeldInTrustAccountMember 2023-09-30 0001843714 us-gaap:CommonClassAMember 2023-09-30 0001843714 us-gaap:CommonClassBMember 2023-09-30 0001843714 wnnr:SponsorCoInvestorMember wnnr:SponsorMember us-gaap:CommonClassBMember 2023-09-30 0001843714 wnnr:ConditionForTheTransferOfFounderSharesBeforeTheLockInPeriodMember us-gaap:CommonClassBMember wnnr:SponsorMember 2023-09-30 0001843714 wnnr:ConsultingServicesAgreementMember 2023-09-30 0001843714 us-gaap:CommonClassAMember wnnr:FounderMember srt:MaximumMember 2023-09-30 0001843714 wnnr:PublicWarrantsMember 2023-09-30 0001843714 wnnr:PrivateWarrantsMember 2023-09-30 0001843714 wnnr:EventTriggeringTheRedemptionOfPublicWarrantsMember wnnr:PublicWarrantsMember 2023-09-30 0001843714 wnnr:EventTriggeringTheExcercieePriceOfWarrantsMember wnnr:PublicWarrantsMember 2023-09-30 0001843714 us-gaap:PrivatePlacementMember wnnr:PrivatePlacementWarrantsMember 2023-09-30 0001843714 us-gaap:IPOMember 2023-09-30 0001843714 srt:MinimumMember 2023-09-30 0001843714 srt:MinimumMember wnnr:BusinessCombinationMember 2023-09-30 0001843714 wnnr:SharePriceLessThanTenPointTwentyFiveMember wnnr:PublicSharesMember 2023-09-30 0001843714 wnnr:PublicSharesMember 2023-09-30 0001843714 wnnr:MeasurementInputProbabilityMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:MeasurementInputExpectedDividendRateMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:MeasurementInputSharePriceMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:MeasurementInputExercisePriceMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:MeasurementInputOptionVolatilityMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:MeasurementInputExpectedTermMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:MeasurementInputRiskFreeInterestRateMember wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 wnnr:DuffAndPhelpsMember 2023-09-30 0001843714 wnnr:BassBerrySimsPlcMember 2023-09-30 0001843714 wnnr:MacfarlanesLLPMember 2023-09-30 0001843714 wnnr:CasselsBrockAndBlackwellLlpMember 2023-09-30 0001843714 wnnr:DuffAndPhelpsMember us-gaap:AccruedLiabilitiesMember 2023-09-30 0001843714 wnnr:PrivatePlacementWarrantsMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:SponsorMember 2023-09-30 0001843714 wnnr:SharePriceEqualOrExceedsTwelveRupeesPerDollarMember wnnr:SponsorMember wnnr:SponsorSharesMember 2023-09-30 0001843714 wnnr:SharePriceEqualOrExceedsTwelveRupeesPerDollarMember wnnr:SponsorMember wnnr:SPACCommonStockMember wnnr:BusinessCombinationAgreementMember 2023-09-30 0001843714 wnnr:AmountOfCashAvailableEqualToTwentyFiveMillionOrMoreMember wnnr:SponsorSharesMember 2023-09-30 0001843714 wnnr:AmountOfCashAvailableEqualToTenMillionOrLessMember wnnr:SponsorSharesMember 2023-09-30 0001843714 wnnr:AmountOfCashAvailableMoreThanTenMillionButLessThanTwentyFiveMillionMember wnnr:SponsorSharesMember srt:MinimumMember 2023-09-30 0001843714 wnnr:AmountOfCashAvailableMoreThanTenMillionButLessThanTwentyFiveMillionMember wnnr:SponsorSharesMember srt:MaximumMember 2023-09-30 0001843714 wnnr:SponsorSharesMember 2023-09-30 0001843714 wnnr:MarketableSecuritiesHeldInTrustAccountMember 2022-12-31 0001843714 us-gaap:CommonClassAMember 2022-12-31 0001843714 us-gaap:CommonClassBMember 2022-12-31 0001843714 wnnr:PublicWarrantsMember 2022-12-31 0001843714 wnnr:PrivateWarrantsMember 2022-12-31 0001843714 wnnr:ConvertiblePromissoryNotesMember 2022-12-31 0001843714 wnnr:SponsorMember wnnr:AdministrativeSupportAgreementMember 2022-01-01 2022-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001843714 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001843714 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001843714 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001843714 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001843714 wnnr:SponsorMember wnnr:AdministrativeSupportAgreementMember 2022-07-01 2022-09-30 0001843714 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001843714 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001843714 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001843714 us-gaap:CapitalUnitsMember 2023-01-01 2023-09-30 0001843714 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001843714 wnnr:SponsorMember us-gaap:CommonClassBMember wnnr:SponsorCoInvestorMember 2023-01-01 2023-09-30 0001843714 wnnr:ConditionForTheTransferOfFounderSharesBeforeTheLockInPeriodMember us-gaap:CommonClassBMember wnnr:SponsorMember 2023-01-01 2023-09-30 0001843714 wnnr:SponsorMember wnnr:AdministrativeSupportAgreementMember 2023-01-01 2023-09-30 0001843714 wnnr:PublicWarrantsMember 2023-01-01 2023-09-30 0001843714 wnnr:EventTriggeringTheRedemptionOfPublicWarrantsMember wnnr:PublicWarrantsMember 2023-01-01 2023-09-30 0001843714 wnnr:EventTriggeringTheExcercieePriceOfWarrantsMember wnnr:PublicWarrantsMember 2023-01-01 2023-09-30 0001843714 wnnr:PrivateWarrantsMember 2023-01-01 2023-09-30 0001843714 wnnr:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001843714 us-gaap:IPOMember 2023-01-01 2023-09-30 0001843714 srt:MinimumMember 2023-01-01 2023-09-30 0001843714 srt:MaximumMember 2023-01-01 2023-09-30 0001843714 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001843714 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001843714 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-01-01 2023-09-30 0001843714 us-gaap:FairValueInputsLevel3Member wnnr:ConvertiblePromissoryNotesMember 2023-01-01 2023-09-30 0001843714 wnnr:MackenziePartnersIncMember 2023-01-01 2023-09-30 0001843714 wnnr:DuffAndPhelpsMember 2023-01-01 2023-09-30 0001843714 wnnr:KpmgLlpMember 2023-01-01 2023-09-30 0001843714 wnnr:SponsorMember wnnr:SPACCommonStockMember wnnr:BusinessCombinationAgreementMember 2023-01-01 2023-09-30 0001843714 wnnr:SponsorMember wnnr:SponsorSharesMember 2023-01-01 2023-09-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001843714 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001843714 wnnr:SponsorMember wnnr:AdministrativeSupportAgreementMember 2023-07-01 2023-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001843714 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001843714 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001843714 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-07-01 2023-09-30 0001843714 wnnr:ConvertiblePromissoryNotesMember us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001843714 wnnr:KpmgLlpMember 2023-07-01 2023-09-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001843714 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001843714 wnnr:ConvertiblePromissoryNotesMember us-gaap:FairValueInputsLevel3Member 2023-04-01 2023-06-30 0001843714 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001843714 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001843714 wnnr:ConvertiblePromissoryNotesMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001843714 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001843714 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001843714 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001843714 wnnr:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001843714 us-gaap:OverAllotmentOptionMember wnnr:PublicSharesMember 2022-01-18 2022-01-18 0001843714 us-gaap:IPOMember wnnr:PublicSharesMember 2022-01-18 2022-01-18 0001843714 wnnr:TheSponsorAndSponsorCoInvestorMember us-gaap:PrivatePlacementMember wnnr:PrivatePlacementWarrantsMember 2022-01-18 2022-01-18 0001843714 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2022-01-18 2022-01-18 0001843714 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-01-18 2022-01-18 0001843714 us-gaap:IPOMember 2022-01-18 2022-01-18 0001843714 us-gaap:OverAllotmentOptionMember wnnr:PublicSharesMember 2022-01-18 0001843714 wnnr:TheSponsorAndSponsorCoInvestorMember us-gaap:PrivatePlacementMember wnnr:PrivatePlacementWarrantsMember 2022-01-18 0001843714 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2022-01-18 0001843714 us-gaap:CommonClassAMember wnnr:PrivatePlacementWarrantsMember 2022-01-18 0001843714 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-01-18 0001843714 wnnr:PublicWarrantMember us-gaap:CommonClassAMember 2022-01-18 0001843714 us-gaap:IPOMember 2022-01-18 0001843714 us-gaap:CommonClassBMember 2021-01-28 2021-01-28 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember 2021-01-28 2021-01-28 0001843714 wnnr:SponsorMember us-gaap:CommonClassBMember wnnr:JohanJRomanelliMember 2021-03-02 2021-03-02 0001843714 wnnr:SponsorMember us-gaap:CommonClassBMember wnnr:CassandraSLeeMember 2021-03-02 2021-03-02 0001843714 wnnr:SponsorMember us-gaap:CommonClassBMember wnnr:ZakaryCBrownMember 2021-03-02 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember wnnr:GeraldDPutnamMember 2021-03-02 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember wnnr:JamesWKeyesMember 2021-03-02 2021-03-02 0001843714 wnnr:CassandraSLeeMember wnnr:SponsorMember us-gaap:CommonClassBMember 2021-03-02 0001843714 wnnr:SponsorMember us-gaap:CommonClassBMember wnnr:JamesWKeyesMember 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember wnnr:JohanJRomanelliMember 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember wnnr:GeraldDPutnamMember 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember wnnr:ZakaryCBrownMember 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember 2021-03-02 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember 2021-11-17 2021-11-17 0001843714 us-gaap:CommonClassBMember wnnr:SponsorMember 2021-11-17 0001843714 wnnr:SponsorMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember 2022-01-12 0001843714 wnnr:SponsorMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:AmendementToThePromissoryNoteMember 2021-01-28 0001843714 wnnr:SponsorMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:AmendementToThePromissoryNoteMember 2021-12-17 0001843714 wnnr:SponsorMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember 2023-01-25 0001843714 wnnr:MichaelM.AndrettiMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember 2023-03-29 0001843714 wnnr:WilliamM.BrownMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember 2023-03-29 0001843714 wnnr:WilliamJ.SandbrookMember wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember 2023-03-29 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-03-29 0001843714 wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:MichaelM.AndrettiMember 2023-05-17 0001843714 wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:WilliamM.BrownMember 2023-05-17 0001843714 wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:WilliamJ.SandbrookMember 2023-05-17 0001843714 wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:WilliamM.BrownMember 2023-05-23 0001843714 wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:WilliamJ.SandbrookMember 2023-05-23 0001843714 wnnr:UnsecuredPromissoryNoteIssuedToRelatedPartyMember wnnr:MichaelM.AndrettiMember 2023-05-23 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-01-26 2023-01-26 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-01-26 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-03-29 2023-03-29 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-04-27 2023-04-27 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-04-27 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-05-19 2023-05-19 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-05-19 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-06-02 2023-06-02 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-06-02 0001843714 wnnr:KpmgLlpMember 2023-01-31 0001843714 wnnr:DuffAndPhelpsMember 2023-01-31 0001843714 wnnr:DuffAndPhelpsMember 2023-01-24 0001843714 wnnr:KpmgLlpMember 2023-04-12 0001843714 wnnr:MackenziePartnersIncMember 2023-06-12 0001843714 us-gaap:CommonClassAMember 2023-11-06 0001843714 us-gaap:CommonClassBMember 2023-11-06 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-08-31 2023-08-31 0001843714 wnnr:ConvertiblePromissoryNotesMember 2023-08-31 0001843714 us-gaap:SubsequentEventMember 2023-11-01 0001843714 wnnr:UnaffiliatedThirdPartiesMember wnnr:NonRedemptionAgreementsMember 2023-07-06 0001843714 wnnr:NonRedemptionAgreementsMember us-gaap:CommonClassBMember 2023-07-06 2023-07-06 0001843714 wnnr:DentonsMember 2023-08-28 2023-08-28 0001843714 wnnr:ClosingOfTheInitialBusinessCombinationMember wnnr:CapitalMarketsAdvisorFeeMember 2023-07-04 0001843714 wnnr:PostBusinessCombinationEventMember wnnr:CapitalMarketsAdvisorFeeMember 2023-07-04 0001843714 wnnr:PostInitialBusinessCombinationMember wnnr:CapitalMarketsAdvisorFeeMember 2023-07-04 0001843714 wnnr:KrollAssociatesIncMember wnnr:DueDiligenceServicesMember 2023-07-05 0001843714 wnnr:ZapataComputingIncMember 2023-09-06 0001843714 wnnr:ZapataComputingIncMember 2023-09-06 2023-09-06 0001843714 wnnr:KpmgLlpMember 2023-03-31 0001843714 wnnr:SponsorMember wnnr:AdministrativeSupportAgreementMember 2022-01-12 2022-01-12 0001843714 us-gaap:RetainedEarningsMember 2022-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001843714 us-gaap:RetainedEarningsMember 2023-09-30 0001843714 us-gaap:FairValueInputsLevel3Member wnnr:ConvertiblePromissoryNotesMember 2023-09-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001843714 us-gaap:RetainedEarningsMember 2023-06-30 0001843714 us-gaap:FairValueInputsLevel3Member wnnr:ConvertiblePromissoryNotesMember 2023-06-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001843714 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001843714 us-gaap:RetainedEarningsMember 2022-06-30 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001843714 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001843714 us-gaap:RetainedEarningsMember 2022-12-31 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001843714 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001843714 us-gaap:RetainedEarningsMember 2023-03-31 0001843714 us-gaap:FairValueInputsLevel3Member wnnr:ConvertiblePromissoryNotesMember 2022-12-31 0001843714 us-gaap:FairValueInputsLevel3Member wnnr:ConvertiblePromissoryNotesMember 2023-03-31 0001843714 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001843714 us-gaap:RetainedEarningsMember 2021-12-31 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001843714 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001843714 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001843714 us-gaap:RetainedEarningsMember 2022-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Year utr:Day utr:Month iso4217:USD xbrli:shares utr:Year xbrli:pure utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
 
(MARK ONE)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2023
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
    
    
    
    
Commission file
number:001-41218
 
 
ANDRETTI ACQUISITION CORP.
(Exact Name of Registrant as Specified in Its Charter)
 
 
 
Cayman Islands
 
98-1578373
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
7615 Zionsville Road
Indianapolis, Indiana 46268
(Address of principal executive offices)
(317)872-2700
(Issuer’s telephone number)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Units, each consisting of one
Class A ordinary share,
$0.0001 par value, and
one-half
of one
redeemable public warrant
 
WNNR.U
 
New York Stock Exchange
Class A ordinary shares, $0.0001 par value
 
WNNR
 
New York Stock Exchange
Public warrants, each whole warrant
exercisable for one Class A ordinary share, each
at an exercise price of $11.50 per share
 
WNNR WS
 
New York Stock Exchange
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T(§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in
Rule 12b-2ofthe
Exchange Act.
 
Large accelerated filer
 
☐
  
Accelerated filer
 
☐
Non-accelerated
filer
 
☒
  
Smaller reporting company
 
☒
 
  
Emerging growth company
 
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined inRule12b-2ofthe
Exchange
Act).    Yes  ☒    No  ☐
As of November 6, 2023, there were 7,894,801 Class A ordinary shares, par value $0.0001 per share, and 5,750,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding.
 
 
 

Table of Contents

ANDRETTI ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2023

TABLE OF CONTENTS

 

     Page  

Part I. Financial Information

   

Item 1. Financial Statements

   

Condensed Consolidated Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022

      3  

Condensed Consolidated Statements of Operations for the Three and Nine Months ended September 30, 2023 and 2022 (Unaudited)

      4  

Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months ended September 30, 2023 and 2022 (Unaudited)

      5  

Condensed Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2023 and 2022 (Unaudited)

      6  

Notes to Condensed Consolidated Financial Statements (Unaudited)

      7  

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

      21  

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk

      28  

Item 4. Controls and Procedures

      28  

Part II. Other Information

   

Item 1. Legal Proceedings

      28  

Item 1A. Risk Factors

      29  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

      29  

Item 3. Defaults Upon Senior Securities

      29  

Item 4. Mine Safety Disclosures

      29  

Item 5. Other Information

      29  

Item 6. Exhibits

      30  

Part III. Signatures

      31  

 

 

i

Table of Contents
P10DP10DP10D
PART I—FINANCIAL INFORMATION
Item 1. Interim Financial Statements.
ANDRETTI ACQUISITION CORP.
CONDENSED COLSOLIDATED BALANCE SHEETS
 
    
September 30,

2023
    
December 31,
2022
  
    
(Unaudited)
        
ASSETS
                 
Current assets
                 
Cash
    $ 157,413     $ 616,120  
Prepaid expenses and other current assets
      199,068       590,883  
    
 
 
    
 
 
  
Total Current Assets
      356,481       1,207,003  
Prepaid insurance, long-term
      —        24,469  
Marketable securities held in Trust Account
      85,132,545       239,149,736  
    
 
 
    
 
 
  
TOTAL ASSETS
   
$
85,489,026
 
  
$
240,381,208
 
    
 
 
    
 
 
  
LIABILITIES AND SHAREHOLDERS’ DEFICIT
                 
Current liabilities
                 
Accounts payable and accrued expenses
    $ 824,979     $ 30,348  
Accrued interest payable – related party
      41,773       —   
Accrued offering costs
      —        85,000  
    
 
 
    
 
 
  
Total Current Liabilities
      866,752       115,348  
Convertible note—related party
      1,653,337       —   
Deferred legal fee
      2,440,000       160,000  
Deferred underwriting fee payable
      8,050,000       8,050,000  
    
 
 
    
 
 
  
Total Liabilities
   
 
13,010,089
 
  
 
8,325,348
 
    
 
 
    
 
 
  
Commitments and Contingencies (see Note 6)
             
Class A ordinary shares subject to possible redemption; $0.0001 par value; 7,894,801 and 23,000,000 shares issued and outstanding at redemption value of $10.78 and $10.40 per share as of September 30, 2023 and December 31, 2022, respectively
      85,132,545       239,149,736  
Shareholders’ Deficit
                 
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
      —        —   
Class A ordinary shares, $0.0001 par value;500,000,000 shares authorized; no shares issued and outstanding (excluding 23,000,000 and no shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively
      —        —   
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022
      575       575  
Additional
paid-in
capital
      —        —   
Accumulated deficit
      (12,654,183 )      (7,094,451 ) 
    
 
 
    
 
 
  
Total Shareholders’ Deficit
   
 
(12,653,608
) 
  
 
(7,093,876
) 
    
 
 
    
 
 
  
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT
   
$
85,489,026
 
  
$
240,381,208
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
3
ANDRETTI ACQUISITION CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
    
For the Three Months Ended
September 30,
    
For the Nine Months Ended
September 30,
  
    
2023
    
2022
    
2023
    
2022
  
Formation costs, professional fees and general and administrative costs
    $ 2,652,552     $ 386,902     $ 6,238,574     $ 1,045,154  
  
 
 
    
 
 
    
 
 
    
 
 
  
Loss from operations
   
 
(2,652,552
) 
  
 
(386,902
) 
  
 
(6,238,574
) 
  
 
(1,045,154
) 
Other income:
         
Interest earned on marketable securities held in Trust Account
      1,604,659       1,071,188       7,024,163       1,405,427  
Change in fair value of Convertible Promissory Notes – Related Party
      (22,210 )      —        (38,199 )      —   
Interest expense – Convertible Promissory Notes – Related Party
      (24,634 )      —        (41,773 )      —   
  
 
 
    
 
 
    
 
 
    
 
 
  
Other income, net
      1,557,815       1,071,188       6,944,191       1,405,427  
Net (loss) income
   
$
(1,094,737
) 
  
$
684,286
 
  
$
705,617
 
  
$
360,273
 
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class A ordinary shares
      11,835,288       23,000,000       19,182,202       21,567,766  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net (loss) income per share, Class A ordinary shares
   
$
(0.06
) 
  
$
0.02
 
  
$
0.03
 
  
$
0.01
 
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class B ordinary shares
      5,750,000       5,750,000       5,750,000       5,703,297  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net (loss) income per share, Class B ordinary shares
   
$
(0.06
) 
  
$
0.02
 
  
$
0.03
 
  
$
0.01
 
  
 
 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
4
ANDRETTI ACQUISITION CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
(UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023
 
    
Class B
Ordinary Shares
     
Additional
Paid-in

Capital
    
Accumulated
Deficit
    
Total
Shareholders’
Deficit
  
    
Shares
     
Amount
                     
Balance – January 1, 2023
   
 
5,750,000
 
   
$
575
 
    $ —     
$
(7,094,451
) 
  
$
(7,093,876
) 
Proceeds received in excess of fair value of convertible promissory notes
      —         —         288,221       —        288,221  
Accretion for Class A ordinary shares to redemption amount
      —         —         (288,221 )      (2,249,443 )      (2,537,664 ) 
Net income
      —         —         —        267,108       267,108  
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance – March 31, 2023
   
 
5,750,000
 
   
 
575
 
   
 
— 
 
  
 
(9,076,786
) 
  
 
(9,076,211
) 
Proceeds received in excess of fair value of convertible promissory note
s
      —         —         375,050       —        375,050  
Accretion for Class A ordinary shares to redemption amount
      —         —         (375,050 )      (2,506,790 )      (2,881,840 ) 
Net income
      —         —         —        1,533,246       1,533,246  
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance – June 30, 2023
   
 
5,750,000
 
   
 
575
 
   
 
— 
 
  
 
(10,050,330
) 
  
 
(10,049,755
) 
Proceeds received in excess of fair value of convertible promissory notes
      —         —         95,543       —        95,543  
Accretion for Class A ordinary shares to redemption amount
      —         —         (95,543 )      (1,509,116 )      (1,604,659 )
Net loss
      —         —         —        (1,094,737 )      (1,094,737 )
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance – September 30, 2023
   
 
5,750,000
 
   
$
575
 
   
$
— 
 
  
$
(12,654,183
) 
  
$
(12,653,608
) 
  
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022
 
    
Class B
Ordinary Shares
    
Additional
Paid-in

Capital
    
Accumulated
Deficit
    
Total
Shareholders’
Equity
(Deficit)
  
    
Shares
    
Amount
                    
Balance – January 1, 2022
   
 
5,750,000
 
  
$
575
 
  
$
24,425
 
  
$
(10,861
) 
  
$
14,139
 
Sale of 13,550,000 Private Placement Warrants
      —        —        13,550,000       —        13,550,000  
Proceeds allocated to Public Warrants
      —        —        6,440,000       —        6,440,000  
Forfeiture of Class B shares by Sponsor for reissuance to Anchor Investor
      (1,430,923 )      (143 )      143       —        —   
Purchase of Class B shares by Anchor Investor including excess fair value over purchase price
      1,430,923       143       10,408,888       —        10,409,031  
Value of transaction costs allocated to fair value equity instruments
      —        —        (707,430 )      —        (707,430 ) 
Remeasurement for Class A ordinary shares to redemption amount
      —        —        (29,716,026 )      (5,574,144 )      (35,290,170 ) 
Net loss
      —        —        —        (276,453 )      (276,453 ) 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance – March 31, 2022
   
 
5,750,000
 
  
 
575
 
  
 
— 
 
  
 
(5,861,458
) 
  
 
(5,860,883
) 
Accretion for Class A ordinary shares to redemption amount
      —        —        —        (334,239 )      (334,239 ) 
Net loss
      —        —        —        (47,560 )      (47,560 ) 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance – June 30, 2022
   
 
5,750,000
 
  
 
575
 
  
 
— 
 
  
$
(6,243,257
) 
  
 
(6,242,682
) 
Accretion for Class A ordinary shares to redemption amount
      —        —        —        (1,071,188 )      (1,071,188 ) 
Net income
      —        —        —        684,286       684,286  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance – September 30, 2022
   
 
5,750,000
 
  
 
575
 
  
 
— 
 
  
$
(6,630,159
) 
  
 
(6,629,584
) 
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
5
ANDRETTI ACQUISITION CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
 
    
For the Nine Months Ended
September 30,
  
    
2023
    
2022
  
Cash Flows from Operating Activities:
     
Net income
    $ 705,617     $ 360,273  
Adjustments to reconcile net income to net cash used in operating activities:
     
Change in fair value of Convertible Promissory Notes – Related Party
      38,199       —   
Interest earned on marketable securities held in Trust Account
      (7,024,163 )      (1,405,427 ) 
Changes in operating assets and liabilities:
     
Prepaid expenses and other current assets
      391,815       (612,572 ) 
Prepaid insurance, long-term
      24,469       (171,281 ) 
Deferred legal fee payable
      2,280,000       28,000  
Accrued interest payable
      41,773       —   
Accrued expenses
      794,631       60,063  
  
 
 
    
 
 
  
Net cash used in operating activities
   
 
(2,747,659
) 
  
 
(1,740,944
) 
  
 
 
    
 
 
  
Cash Flows from Investing Activities:
     
Investment of cash in Trust Account
      —        (235,750,000 ) 
Cash withdrawn from Trust Account in connection with redemption
      161,041,354       —   
  
 
 
    
 
 
  
Net cash provided by (used in) investing activities
   
 
161,041,354
 
  
 
(235,750,000
) 
  
 
 
    
 
 
  
Cash Flows from Financing Activities:
     
Proceeds from issuance of Class B ordinary shares to Anchor Investor
      —        6,221  
Proceeds from sale of Units, net of underwriting discounts paid
      —        225,400,000  
Proceeds from sale of Private Placement Warrants
      —        13,550,000  
Proceeds from promissory note – Related Party
      —        75  
Proceeds from convertible promissory notes— Related Party
      2,373,952       —   
Repayment of promissory note – Related Party
      —        (240,629 ) 
Payment of offering costs
      (85,000 )      (417,146 ) 
Redemption of Class A ordinary shares
      (161,041,354 )      —   
  
 
 
    
 
 
  
Net cash (used in) provided by financing activities
   
 
(158,752,402
) 
  
 
238,298,521
 
  
 
 
    
 
 
  
Net Change in Cash
   
 
(458,707
) 
  
 
807,577
 
Cash – Beginning of period
      616,120       —   
  
 
 
    
 
 
  
Cash – End of period
   
$
157,413
 
  
$
807,577
 
  
 
 
    
 
 
  
Non-Cash
investing and financing activities:
     
Accretion of Class A ordinary shares to redemption amount
    $ 7,024,163     $ 1,405,427  
  
 
 
    
 
 
  
Proceeds received from convertible promissory notes in excess of initial fair value
    $ 758,814     $ —   
  
 
 
    
 
 
  
Offering costs included in accrued offering costs
    $ —      $ 85,000  
  
 
 
    
 
 
  
Excess fair value of Founder shares attributable to Anchor Investor
    $ —      $ 10,402,810  
  
 
 
    
 
 
  
Remeasurement of Class A ordinary shares to redemption amount
    $ —      $ 35,290,170  
  
 
 
    
 
 
  
Deferred underwriting fee payable
    $ —      $ 8,050,000  
  
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
6
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Andretti Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 20, 2021. The Company was incorporated for the purpose of effecting a merger, consolidation share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). On August 18, 2023, the Company formed Tigre Merger Sub, Inc. a wholly owned subsidiary of the Company.
The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
All activity for the period from January 20, 2021 (inception) through September 30, 2023 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering.
On January 18, 2022, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares” or the “Class A Ordinary Shares”), which includes the full exercise by the underwriters of its over-allotment option in the amount of 3,000,000 Units at $10.00 per Unit, generating gross proceeds of $230,000,000, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 13,550,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Andretti Sponsor LLC (the “Sponsor”) and a third party institutional accredited investor (the “Sponsor
Co-Investor”),
generating gross proceeds of $13,550,000, which is described in Note 4.
Transaction costs amounted to $23,807,600, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees, $10,402,810 for the fair value of the Founder Shares attributable to the Sponsor
Co-Investors
 
(see
Note 5), and $754,790 of other offering costs.
Following the closing of the Initial Public Offering on January 18, 2022, an amount of $235,750,000 ($10.25 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), to be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions
of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company.
The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.25 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The
per-share
amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights in connection with a Business Combination with respect to the Company’s warrants.
The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement that may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
 
7
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.
The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or
pre-initial
business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.
The Company’s Amended and Restated Memorandum and Articles of Association previously provided that the Company will have (i) the
18-month
period from the closing of the Initial Public Offering in which the Company must complete a Business Combination, (ii) the
21-month
or
24-month,
as applicable, period from the closing of the Initial Public Offering in which the Company must complete a Business Combination if the Sponsor has extended the period of time for the Company to complete a Business Combination by purchasing additional Private Placement Warrants, or (iii) such other extended time period in which the Company must complete a Business Combination pursuant to an amendment to its Amended and Restated Memorandum and Articles of Association(the “Combination Period”). At the special meeting of the Company held on July 14, 2023, shareholders of the Company approved an amendment to the Company’s Amended and Restated Memorandum and Articles of Association to extend the Combination Period to April 18, 2024. However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate of
 
15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$
84.2
 
million remained in the trust account (based on the redemption amount of
 
$
10.66
per share).
The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.25).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.25 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.25 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
 
8
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
Risks and Uncertainties
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed consolidated financial statements.
Going Concern Consideration
As of September 30, 2023, we had cash of $157,413 and working capital deficit of $510,271.
Until the consummation of a Business Combination, the Company will be using the funds held outside the Trust Account for identifying and evaluating target businesses, performing due diligence on prospective target businesses, paying for travel expenditures, reviewing corporate documents and material agreements of prospective target businesses, and structuring, negotiating and completing a Business Combination.
The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If the Company is unable to complete the Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued.
In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB’s”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by April 18, 2024 (or such later date as may be approved by shareholder vote), then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 18, 2024 (or such later date as may be approved by shareholder vote).
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 22, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and Shareholder approval of any golden parachute payments not previously approved.
 
9
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
 
Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Marketable Securities Held in Trust Account
At September 30, 2023 and December 31, 2022, all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities.
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate of
 
15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$
84.2
 
million remained in the trust account (based on the redemption amount of
 
$
10.66
per share).
Convertible Promissory Notes—Related Party
The Company accounts for its convertible promissory notes under ASC 815, Derivatives and Hedging (“ASC 815”). Under ASC
815-15-25,
the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the notes and fair value at each drawdown date are recognized as either an expense in the condensed consolidated statements of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the condensed consolidated statements of operations. The fair value of the option to convert into private warrants was valued utilizing the closed-form model.
Offering Costs
The Company complies with the requirements of Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. Offering
costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs amounted to $23,807,600, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees, $10,402,810 for the fair value of the Founder Shares attributable to the Sponsor
Co-Investor
 
(see
Note 5), and $754,790 of other offering costs. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to the total proceeds received. Offering costs associated with the Class A ordinary shares were charged against their carrying value and offering costs associated with the warrants were charged to additional
paid-in
capital.
 
10
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” (“ASC 480”) Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’(deficit) equity. The Company’s Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A Ordinary Shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A Ordinary Shares are affected by charges against additional paid in capital and accumulated deficit.
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
 
11
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,500,000 Class A ordinary shares in the aggregate. As of September 30, 2023, the Company had dilutive securities that are Public Warrants that could potentially be exercised into ordinary shares and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented.
 
   
For the Three Months Ended
September 30,
    
For the Nine Months Ended
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
   
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
  
Basic and diluted net (loss) income per ordinary share
                                                                
Numerator:
                                                                
Allocation of net (loss) income, as adjusted
   $ (736,782 )    $ (357,955 )    $ 547,429     $ 136,857     $ 542,884     $ 162,733     $ 284,928     $ 75,345  
Denominator:
                                                                
Basic and diluted weighted average shares outstanding
     11,835,288       5,750,000       23,000,000       5,750,000       19,182,202       5,750,000       21,567,766       5,703,297  
Basic and diluted net (loss) income per ordinary share
   $ (0.06 )    $ (0.06 )    $ 0.02     $ 0.02     $ 0.03     $ 0.03     $ 0.01     $ 0.01  
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. The Company had not experienced losses on this account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed consolidated balance sheets, primarily due to their short-term nature.
Warrant Instruments
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the instruments are outstanding. Upon further review of the warrant agreements, management concluded that the Public Warrants and Private Placement Warrants to be issued pursuant to the warrant agreements qualify for equity accounting treatment.
Share-Based Compensation
The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations.
 
12
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
Recent Accounting Standards
In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13–Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.
NOTE 3 — PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 23,000,000 Units, which included a full exercise by the underwriter of its over-allotment option in the amount of 3,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A Ordinary Share and
one-half
of one redeemable public warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A Ordinary Share at an exercise price of $11.50 per whole share (see Note 7).
NOTE 4 — PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor and SOL Verano Blocker 1 LLC, a Delaware limited liability company and a third party institutional accredited investor (the “Sponsor
Co-Investor”),
 
purchased
an aggregate of 13,550,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $13,550,000, in a private placement transaction. Each Private Placement Warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
NOTE 5 — RELATED PARTY TRANSACTIONS
Founder Shares
On January 28, 2021, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 7,187,500 Class B Ordinary Shares (the “Founder Shares”). On March 2, 2021, the Sponsor transferred 30,000 Founder Shares to Cassandra S. Lee for the consideration of $104.35 (approximately $0.003 per share) and 25,000 Founder Shares to each of Zakary C. Brown, James W. Keyes, Gerald D. Putnam and John J. Romanelli, in each case for the consideration of $86.96 (approximately $0.003 per Founder Share), resulting in the Sponsor holding 7,057,500 Founder Shares. On November 17, 2021, the Sponsor surrendered an aggregate of 1,437,500 Founder Shares for no consideration, thereby reducing the aggregate number of Founder Shares held by the Sponsor to 5,620,000 Founder Shares. Immediately prior to the Initial Public Offering, the Sponsor forfeited 1,430,923 Founder Shares in connection with the issuance of Founder Shares to the Sponsor
Co-Investor.
The Company entered into agreements with the Sponsor
Co-Investor,
pursuant to which such Sponsor
Co-Investor
purchased (i) an aggregate of approximately 25% of the issued and outstanding, or 1,430,923 Founder Shares, and (ii) an aggregate of 3,450,000 Private Placement Warrants from the Sponsor immediately prior to the closing of the Initial Public Offering. The Sponsor
Co-Investor
entered into an agreement to vote all of the Founder Shares it owns in favor of an initial Business Combination and will also agree not to redeem any Founder Shares it owns in connection with the completion of the initial Business Combination. The Sponsor
Co-Investor
was not granted any material additional shareholder or other rights, other than the Founder Shares.
Subject to the Sponsor
Co-Investor
purchasing 100% of the Founder Shares allocated to it, in connection with the closing of the Initial Public Offering, the Sponsor sold an aggregate of 1,430,923 Founder Shares to the Sponsor
Co-Investor
at their original purchase price of $.0043 per share. The Company estimated the aggregate fair value of the Founder Shares attributable to the Sponsor
Co-Investor
to be $10,402,810, or $7.27 per share. The excess of the fair value of the Founder Shares was determined to be a contribution to the Company from the founders in accordance with Staff Accounting Bulletin (SAB) Topic 5T and an offering cost in accordance with SAB Topic 5A. Accordingly, the offering costs were recorded against additional paid in capital in accordance with the accounting of other offering costs.
 
13
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any30-tradingday period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property.
On July 6, 2023, the Company and Sponsor, entered into
non-redemption
agreements (the
“Non-Redemption
Agreements”) with unaffiliated third parties (the “Investors”). Pursuant to the
Non-Redemption
Agreements, the Investors agreed not to redeem an aggregate of 3.5 million Class A ordinary shares of the Company (the
“Non-Redeemed
Shares”) in connection with the Extraordinary General Meeting held. In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to the Investors an aggregate of 875,000 Class B ordinary shares of the Company held by the Sponsor immediately following consummation of an initial business combination if the Investors continue to hold such
Non-Redeemed
Shares through the Extraordinary General Meeting. The transfer of these shares are contingent upon the business combination, as such no expense has been recorded as of September 30, 2023.
Administrative Support Agreement
The Company entered into an agreement commencing on January 12, 2022 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $15,000 per month for office space and administrative and support services. For the three and nine months ended September 30, 2023, the Company incurred and paid $45,000 and $135,000 in fees for these services, respectively. For the three and nine months ended September 30, 2022, the Company incurred and paid $45,000 and $128,710 in fees for these services, respectively.
Promissory Note — Related Party
On January 28, 2021, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On December 17, 2021, the Company and the Sponsor agreed to amend the Promissory Note to increase the aggregate principal amount of the Promissory Note to $400,000 and to change the date by which the Promissory Note was payable. The Promissory Note, as amended, was
non-interest
bearing and payable on the earlier of December 31, 2022 and the completion of the Initial Public Offering. The total outstanding loan of $240,629 was repaid at the time of the Initial Public Offering, on January 18, 2022. Borrowings under the Promissory Note are no longer available.
Convertible Promissory Notes – Related Party
In order to finance transaction costs in connection with a Business Combination, the Company issued unsecured promissory notes (collectively, the “Notes”) to the Sponsor on January 25, 2023, Michael M. Andretti, William J. Sandbrook, and William M. Brown all on March 29, 2023 (collectively, the “Payees”), in the amounts of up to $375,000, $500,000, $500,000, and $100,000, respectively. The proceeds of the Notes, which may be drawn down from time to time until the Company consummates the initial Business Combination, will be used for general working capital purposes. The Notes bear interest of 4.50% per annum and are payable in full upon the earlier to occur of (i) the date on which the Company consummates an initial business combination or (ii) the liquidation date of the Company in accordance with its amended and restated memorandum and articles of association. A failure to pay the principal and accrued interest within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall be deemed an event of default, in which case the Notes may be accelerated. At the election of the Payees, up to $1,500,000 of the principal amounts of the Notes may be converted into private placement warrants of the Company, with such terms as are described in the prospectus included in the registration statement on
FormS-1
(Reg.No. 333-254627)
filed by the Company with the Securities and Exchange Commission and declared effective on January 12, 2022, at a price of $1.00 per warrant. The terms of the Conversion Warrants would be identical to the warrants issued by the Company to the Sponsor in a private placement that was consummated in connection with the Initial Public Offering. The Payees shall be entitled to certain registration rights relating to the Conversion Warrants. The issuance of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. If the Company completes a Business Combination, the Company will repay the Notes out of the proceeds of the Trust Account released to the Company. Otherwise, the Notes will be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Notes, but no proceeds held in the Trust Account will be used to repay the Notes. On May 17, 2023, the notes were amended and restated to increase the total borrowing amounts to $800,000 for Michael M. Andretti, $800,000 for William J. Sandbrook, and $160,000 for William M. Brown. On May 23, 2023, the notes were amended and restated to increase the total borrowing amounts to $1,400,000 for Michael M. Andretti, $1,400,000 for William J. Sandbrook, and $280,000 for William M. Brown. The notes are payable upon the earlier of the liquidation of the Company or the consummation of initial business combination.
At September 30, 2023, there was $2,373,952 of cumulative cash advanced under the Notes. The Notes were valued using the fair value method. The initial advances on the Notes totaling $2,373,952, consisting of draws of $175,000 at January 26, 2023, $725,555 at March 29, 2023, $225,001 at April 27, 2023, $234,869 at May 19, 2023, $713,527 at June 2, 2023 and $300,000 at August 31, 2023 were valued at $119,391 as of January 26, 2023, $492,943 as of March 29, 2023, $153,288 at April 27, 2023, $160,231 at May 19, 2023, $484,828 at June 2, 2023 and $204,457 at August 31, 2023 whereas the collective difference of $758,814 was recorded as a credit to shareholders’ deficit. The change in the fair value of the note recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023, was $22,210 and $38,199, respectively, resulting in a fair value of the Notes of $1,653,337 (see Note 8).
 
14
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
NOTE 6 — COMMITMENTS AND CONTINGENCIES
Registration and Shareholders Rights
Pursuant to a registration and shareholder rights agreement entered into on January 12, 2022, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provide that no sales of these securities will be effected until after the expiration of the applicable lockup period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
On September 25, 2023, the Company received a letter from RBC Capital Markets, LLC waiving their rights to the deferred underwriting fee subject to the closing of the announced proposed business combination with Zapata Computing.
Consulting Agreements
On February 16, 2021, the Company entered into a consulting agreement with ICR, LLC (“ICR”), pursuant to which ICR will provide investor and media relations support in connection with the search for a potential Business Combination. The fees in connection with the services rendered are expensed as incurred. In connection with the consulting agreement, a success fee of $250,000 is due and payable solely upon successful completion of a Business Combination.
 
As such, this fee is not reflected on the Company’s condensed consolidated statements of operation or condensed consolidated balance sheets as of September 30, 2023.
On December 22, 2022, the Company entered into an engagement letter with KPMG LLP (“KPMG”), pursuant to which KPMG will assist the Company in performing due diligence in connection with the initial Business Combination. The Company paid a $275,000
and $450,554
fee in January 2023 and March 2023, respectively, to KPMG in connection with this arrangement. The fees in connection with the services rendered are expensed as incurred and are payable upon the earlier of the termination of KPMG’s engagement and the closing of the Initial Business Combination. During the three and nine months ended September 30, 2023, the Company paid $0 and
$725,554
, respective, towards this engagement and no further balance is due.
On January 24, 2023, the Company entered into a letter agreement with Kroll, LLC (“Duff & Phelps”), pursuant to which Duff & Phelps will serve as an independent financial advisor to the Board of the Company and will provide a fairness opinion regarding the initial Business Combination. The Company paid a $50,000
non-refundable
retainer fee in January 2023 to Duff & Phelps in connection with this arrangement. The Company has agreed to pay Duff & Phelps an additional (i) $150,000 fee payable upon Duff & Phelps informing the Company that it is prepared to deliver a fairness opinion in connection with the initial Business Combination and (ii) $400,000 fee payable upon closing of the initial Business Combination. As of September 30, 2023, the opinion was delivered as such, the Company paid $224,918. As of September 30, 2023, the Company incurred fees totaling $624,918, of which $400,000 is included in accrued expenses on the Company’s condensed consolidated balance sheets.
On January 24, 2023, the Company entered into an engagement letter with Cassels Brock & Blackwell LLP (“Cassels”), pursuant to which Cassels will represent the Company as Canadian counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023 the Company recorded $177,500 to accounts payable on the condensed consolidated balance sheet.
On February 3, 2023, the Company entered into an engagement letter with Macfarlanes LLP (“Macfarlanes”), pursuant to which Macfarlanes will represent the Company as English law counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023 the Company had paid Macfarlanes $472,526. The Company does not expect to incur any additional costs from this agreement.
On April 12, 2023, the Company entered into an engagement letter with KPMG LLP (“KPMG”), pursuant to which KPMG will assist the Company in performing due diligence in connection with a prospective initial Business Combination. The Company paid a total of $459,870 in fees in April and May 2023 to KPMG in connection with this arrangement. In connection with the engagement letter, an additional $919,740 is due and payable upon successful completion of the Business Combination with a specified target company. The fees in connection with the services rendered are expensed as incurred.
On June 12, 2023, the Company entered into a letter agreement with MacKenzie Partners, Inc. (“MacKenzie”), pursuant to which MacKenzie provided advisory, consulting and proxy solicitation services for the Extraordinary General Meeting. The Company agreed to pay MacKenzie a fee of $15,000 plus expenses, payable following the conclusion of the Extraordinary General Meeting. As of September 30, 2023 the Company incurred
and paid
$26,803 of fees
to
 
Mackenzie
.
On June 26, 2023, the Company entered into an engagement letter with Bass, Berry & Sims PLC (“Bass, Berry & Sims”), pursuant to which Bass, Berry & Sims will represent the Company as outside counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023, the Company has paid $22,754 and there
are
 no accrued expenses related to this agreement on the condensed consolidated balance sheet. No further fees are expected in connection with this agreement.
On August 28, 2023, the Company entered into an engagement letter with Dentons UK and Middle East LLP (“Dentons”), pursuant to which Dentons will provide legal advising on any filings requirements as a result of the transaction in Spain or the United Kingdom. The fees in connection with the services rendered are expensed as incurred and are due upon the completion of the initial business combination. As of September 30, 2023, the Company has incurred $27,763
 in fees which
are
 included in accrued expenses on the Company’s condensed consolidated balance sheets
. The Company does expect to incur any additional costs from this agreement.
 
15
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
Legal Fees
As of September 30, 2023 and December 31, 2022, the Company had a total of $2,440,000 and $160,000, respectively, of deferred legal fees to be paid to the Company’s legal advisors upon consummation of the Business Combination, which
are
 included in the accompanying condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, respectively.
Engagement Letter
On July 4, 2023, the Company entered into an engagement letter with Cohen & Company Capital Markets (“Cohen”), pursuant to which Cohen will act as capital markets advisor to the Company in connection with the initial Business Combination. The Company agreed to pay Cohen a fee of (i) $500,000 in cash payable upon the closing of the initial Business Combination, plus (ii) $1,000,000 in either cash or post-Business Combination equity, payable 180 days after the closing of the initial Business Combination plus (iii) $1,000,000 payable in either cash or post-Business Combination equity, payable 270 calendar days following the initial Business Combination.
On July 5, 2023, the Company entered into an engagement letter with Kroll Associates, Inc. (“Kroll”), pursuant to which Kroll will provide due diligence services in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. The Company agreed to pay Kroll a retainer of $10,000, which was paid upon execution of the engagement
letter.
Non-Redemption
Agreements
On July 6, 2023, the Company and Sponsor, entered into
non-redemption
agreements (the
“Non-Redemption
Agreements”) with unaffiliated third parties (the “Investors”). Pursuant to the
Non-Redemption
Agreements, the Investors agreed not to redeem an aggregate of 3.5 million Class A ordinary shares of the Company (the
“Non-Redeemed
Shares”) in connection with the Extraordinary General Meeting held. In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to the Investors an aggregate of 875,000 Class 
B ordinary shares of the Company held by the Sponsor immediately following consummation of an initial business combination if the investors continue to hold such Non-Redeemed Shares through the Extraordinary General Meeting. As a result of the transfer of the shares only occurring at the consummation of an initial business combination, no expense has been recorded as of September 30, 2023. Upon the consummation of the initial business combination, the Company will record an expense which is representative of a capital contribution from the Sponsor.
On July 14, 2023, the Company held an extraordinary general meeting of the Company’s shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved amendments (the “Articles Amendment”) to the Articles to (i) extend the date by which the Company must consummate its initial business combination from July 18, 2023 to April 18, 2024, or such earlier date as determined by the Company’s board of directors in its sole and absolute discretion (the “Extension”), and (ii) eliminate the limitation that the Company shall not redeem its Class A ordinary shares included as part of the units sold in the Company’s initial public offering (such shares, including any shares issued in exchange thereof, the “public shares”) that was consummated on January 18, 2022 (the “IPO”) to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation”).
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate
of 15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$84.2 
million remained in the trust account (based on the redemption amount
 
of
$10.66 per share).
Business Combination Agreement
On September 6, 2023, Andretti Acquisition Corp., a Cayman Islands exempted company incorporated with limited liability, entered into a Business Combination Agreement (as it may be amended and/or restated from time to time, the “Business Combination Agreement”) with Tigre Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”) and Zapata Computing, Inc., a Delaware corporation (“Zapata”).
Merger Consideration
At the effective time of the Merger:
 
  (i)
each share of Zapata’s preferred stock, par value $0.0001 per share (the “Zapata Preferred Stock”) will be converted into the right to receive a number of newly issued shares of New Parent Common Stock equal to the Per Share Preferred Stock Consideration (as defined in the Business Combination Agreement) in accordance with the terms of the Business Combination Agreement;
 
  (ii)
each share of Zapata’s common stock, par value of $0.0001 (the “Zapata Common Stock”) will be converted into the right to receive a number of newly issued shares of New Parent Common Stock equal to the Per Share Common Stock Consideration (as defined in the Business Combination Agreement) in accordance with the terms of the Business Combination Agreement; and
 
16
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
  (iii)
each option to purchase shares of Zapata’s common stock, whether or not exercisable and whether or not vested (each, a “Zapata Option”) will automatically be converted into an option to purchase, on the same terms and conditions as were applicable to such Zapata Option immediately prior to the Effective Time, including applicable vesting conditions, a number of shares of New Parent Common Stock determined in accordance with the terms of the Business Combination Agreement.
The aggregate value of the consideration that the holders of Zapata’s securities collectively shall be entitled to receive from Company in connection with the Business Combination shall not exceed $200,000,000 (calculated with each share of New Parent Common Stock deemed to have a value of $10 per share).
Other Agreements in Connection with the Business Combination Agreement:
Sponsor Support Agreement
Concurrently with the execution of the Business Combination Agreement, SPAC, the Sponsor, and certain key equityholders of the Sponsor entered into a certain Sponsor Support Agreement, which amended and restated in its entirety that certain letter, dated January 12, 2022, by and among such parties. Pursuant to the Sponsor Support Agreement, those certain equityholders who are parties thereto agreed to: (a) vote all shares of the SPAC Common Stock beneficially owned by them (including any additional shares of SPAC Common Stock over which they acquire ownership or the power to vote) in favor of the Merger and all other transactions contemplated by the Business Combination Agreement; (b) the continued lock-up of the founder shares held by such persons for the earlier of (i) one (1) year or (ii) the date on which the post-Closing share price equals or exceeds $12 for twenty (20) trading days in a thirty (30)-trading day period commencing at least one hundred and fifty (150) days after the Closing (or in the event of a liquidation, merger or other similar event); and (c) the continued lock-up of the private placement warrants until thirty (30) days following Closing.
Additionally, the Sponsor Support Agreement provides that the Sponsor Shares are subject to certain vesting and forfeiture conditions based on: (a) the total dollar amount of cash or cash equivalents available in the Trust Account after any redemptions plus (b) the total amount of financing raised by both SPAC and Zapata (including any bridge financing raised by Zapata prior to the Closing Date) to be consummated prior to the consummation of the Merger (all such amounts, the “Closing Available Cash”) as follows:
 
 
•
 
If the Closing Available Cash is an amount equal to $25 million or more, then all Sponsor Shares will be fully vested;
 
 
•
 
If the Closing Available Cash is $10 million or less, then 30% of the Sponsor Shares will be unvested and subject to forfeiture; and
 
 
•
 
If the Closing Available Cash is more than $10 million but less than $25 million then the number of Sponsor Shares that will be unvested and subject to forfeiture will be determined by straight line interpolation between zero and 30% of the number of Sponsor Shares.
Any Sponsor Shares subject to vesting will become vested if, within three years of the Closing, the closing price of the New Company Common Stock on the NYSE (or other exchange or other market where the New Company Common Stock is then traded) equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30 trading day period, or if there is a change of control of the Company. If neither of these events occur within three years of the Closing, then the unvested Sponsor Shares will be forfeited.
The vesting provisions were analyzed under ASC 480 and ASC 815 and determined equity classification was not precluded and should remain classified as permanent equity until the business combination is consummated.
 
17
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
NOTE 7 — SHAREHOLDERS’ DEFICIT
Preference Shares
— The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
— The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there are 7,894,801 and 23,000,000 Class A Ordinary Shares subject to possible redemption and presented as temporary equity, respectively.
Class
 B Ordinary Shares
— The Company is authorized to issue 50,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 5,750,000 Class B ordinary shares issued and outstanding.
Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A Ordinary Shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. In connection with a Business Combination, the Company may enter into a shareholder’s agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other governance arrangements that differ from those in effect upon completion of the Initial Public Offering.
The Class B ordinary shares will automatically convert into Class A Ordinary Shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A Ordinary Shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, deemed issued, or to be issued, to any seller of an interest in the target to the Company in a Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A Ordinary Shares at a rate of less than
one-to-one.
Warrants
– As of September 30, 2023 and December 31, 2022 there are 11,500,000 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of Class A Ordinary Shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary Shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A Ordinary Share upon exercise of a warrant unless the Class A Ordinary Share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
While the Company has registered the Class A Ordinary Shares issuable upon exercise of the Public Warrants under the Securities Act as part of the registration statement of which this prospectus forms a part, the Company does not plan on keeping a prospectus current until required to pursuant to the public warrant agreement. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which this prospectus forms a part or a new registration statement for the registration, under the Securities Act, of the Class A Ordinary Shares issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the closing a Business Combination and to maintain the effectiveness of such post-effective amendment or registration statement and a current prospectus relating thereto until the expiration or redemption of the Public Warrants in accordance with the provisions of the public warrant agreement. If such post-effective amendment or registration statement covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants is not effective by the 60th business day after the closing of a Business Combination, holders of the Public Warrants may, until such time as there is an effective post-effective amendment or registration statement and during any other period when the Company will have failed to maintain an effective registration statement, exercise Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A Ordinary Shares are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their
 
18
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Class A Ordinary Shares issuable upon exercise of the Public Warrants and (y) use its commercially reasonable efforts to register or qualify for sale the Class A Ordinary Shares issuable upon exercise of the warrants under the blue sky laws to the extent an exemption is not available.
Redemption of Public Warrants. Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per Public Warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption to each Public Warrant holder; and
 
  •  
if, and only if, the last reported sale price of the Class A Ordinary Shares has been at least $18.00 per share (subject to adjustment in compliance with the public warrant agreement) for any ten trading days within the20-trading-dayperiod ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Public Warrants.
The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the30-dayredemption period or the Company elected to require the exercise of the Public Warrants on a “cashless basis” as described below. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the Public Warrants for that number of Class A Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Ordinary Shares underlying the Public Warrants, multiplied by the excess of the “fair market value” (as defined below) of the Class A Ordinary Shares over the exercise price of the Public Warrants by (y) the “fair market value.” Solely for purposes of this paragraph, the “fair market value” means the volume-weighted average last reported sale price of the Class A Ordinary Shares as reported for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Public Warrants. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below their exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or holders of the Class B ordinary shares or their respective affiliates, without taking into account any Founder Shares held by the Sponsor, holders of the Class B ordinary shares or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume-weighted average trading price of its Class A Ordinary Shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
As of September 30, 2023 and December 31, 2022 there are 13,550,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are
non-redeemable.
The warrant agreements contain a provision wherein warrant holders can receive an “alternative issuance” (as defined in the applicable warrant agreement), including as a result of a tender offer that constitutes a change of control.
NOTE 8. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820 for its financial assets and liabilities that
are re-measured
and reported at fair value at each reporting period, and
non-financial
assets and liabilities that
are re-measured
and reported at fair value at least annually.
 
19
ANDRETTI ACQUISITION CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2023
(Unaudited)
 
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3:    Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
   
Level
     
September 30, 2023
     
December 31, 2022
  
Assets:
                           
Marketable securities held in Trust Account
      1      $ 85,132,545      $ 239,149,736  
Liabilities:
                           
Convertible promissory notes – related party
      3        1,653,337        –  
The estimated fair value of the convertible promissory notes was based on the following significant inputs:
 
    
September 30,
2023
  
Risk-free interest rate
      4.60 % 
Time to Expiration (in years)
      5.42  
Expected volatility
      8.1 % 
Exercise price
    $ 11.50  
Dividend yield
      0.00 % 
Share Price
    $ 10.75  
Probability of transaction
      70.00 % 
The following table presents the changes in the fair value of the Level 3 convertible promissory notes:
 
Fair value as of January 1, 2023
    $ —   
Borrowings
      900,555  
Proceeds received in excess of initial fair value of convertible promissory notes
      (288,221 ) 
Change in fair value
      608  
    
 
 
  
Fair value as of March 31, 2023
      612,942  
Borrowings
      1,173,397  
Proceeds received in excess of initial fair value of convertible promissory notes
      (375,050 ) 
Change in fair value
      15,381  
    
 
 
  
Fair value as of June 30, 2023
      1,426,670  
Borrowings
      300,000  
Proceeds received in excess of initial fair value of convertible promissory notes
      (95,543 ) 
Change in fair value
      22,210  
    
 
 
  
Fair value as of September 30, 2023
    $ 1,653,337  
    
 
 
  
There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September 30, 2023 for the convertible promissory notes.
NOTE 9 – SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date
that
the unaudited condensed consolidated financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events, that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.
On October 27, 2023, the Company filed the Form
S-4
registration statement in connection with the business combination with Zapata Computing, Inc. Additional information regarding the Company’s business combination with Zapata Computing, Inc., including risk factors regarding the proposed business combination, is included in the registration statement on Form S-4 filed by the Company with the SEC on October 27, 2023.
On November 1, 2023, the Company was advanced $300,000 on the Notes. The cumulative cash advanced under the Notes as of this filing was $2,673,952.
 
 
20

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Andretti Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Andretti Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “predict,” “project,” “target,” “goal,” “shall,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). Additional information regarding the Company’s business combination with Zapata Computing, Inc., including risk factors regarding the proposed business combination, is included in the registration statement on Form S-4 filed by the Company with the SEC on October 27, 2023. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on January 20, 2021 formed for the purpose of effecting a merger, consolidation share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of cash, shares and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Business Combination Agreement

On September 6, 2023, Andretti Acquisition Corp., a Cayman Islands exempted company incorporated with limited liability, entered into a Business Combination Agreement (as it may be amended and/or restated from time to time, the “Business Combination Agreement”) with Tigre Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”) and Zapata Computing, Inc., a Delaware corporation (“Zapata”).

Merger Consideration

At the effective time of the Merger:

 

  (i)

each share of Zapata’s preferred stock, par value $0.0001 per share (the “Zapata Preferred Stock”) will be converted into the right to receive a number of newly issued shares of New Parent Common Stock equal to the Per Share Preferred Stock Consideration (as defined in the Business Combination Agreement) in accordance with the terms of the Business Combination Agreement;

 

  (ii)

each share of Zapata’s common stock, par value of $0.0001 (the “Zapata Common Stock”) will be converted into the right to receive a number of newly issued shares of New Parent Common Stock equal to the Per Share Common Stock Consideration (as defined in the Business Combination Agreement) in accordance with the terms of the Business Combination Agreement; and

 

  (iii)

each option to purchase shares of Zapata’s common stock, whether or not exercisable and whether or not vested (each, a “Zapata Option”) will automatically be converted into an option to purchase, on the same terms and conditions as were applicable to such Zapata Option immediately prior to the Effective Time, including applicable vesting conditions, a number of shares of New Parent Common Stock determined in accordance with the terms of the Business Combination Agreement.

The aggregate value of the consideration that the holders of Zapata’s securities collectively shall be entitled to receive from Company in connection with the Business Combination shall not exceed $200,000,000 (calculated with each share of New Parent Common Stock deemed to have a value of $10 per share).

 

21

Table of Contents

Other Agreements in Connection with the Business Combination Agreement:

Sponsor Support Agreement

Concurrently with the execution of the Business Combination Agreement, SPAC, the Sponsor, and certain key equityholders of the Sponsor entered into a certain Sponsor Support Agreement, which amended and restated in its entirety that certain letter, dated January 12, 2022, by and among such parties. Pursuant to the Sponsor Support Agreement, those certain equityholders who are parties thereto agreed to: (a) vote all shares of the SPAC Common Stock beneficially owned by them (including any additional shares of SPAC Common Stock over which they acquire ownership or the power to vote) in favor of the Merger and all other transactions contemplated by the Business Combination Agreement; (b) the continued lock-up of the founder shares held by such persons for the earlier of (i) one (1) year or (ii) the date on which the post-Closing share price equals or exceeds $12 for twenty (20) trading days in a thirty (30)-trading day period commencing at least one hundred and fifty (150) days after the Closing (or in the event of a liquidation, merger or other similar event); and (c) the continued lock-up of the private placement warrants until thirty (30) days following Closing.

Additionally, the Sponsor Support Agreement provides that the Sponsor Shares are subject to certain vesting and forfeiture conditions based on: (a) the total dollar amount of cash or cash equivalents available in the Trust Account after any redemptions plus (b) the total amount of financing raised by both SPAC and Zapata (including any bridge financing raised by Zapata prior to the Closing Date) to be consummated prior to the consummation of the Merger (all such amounts, the “Closing Available Cash”) as follows:

 

  •  

If the Closing Available Cash is an amount equal to $25 million or more, then all Sponsor Shares will be fully vested;

 

  •  

If the Closing Available Cash is $10 million or less, then 30% of the Sponsor Shares will be unvested and subject to forfeiture; and

 

  •  

If the Closing Available Cash is more than $10 million but less than $25 million then the number of Sponsor Shares that will be unvested and subject to forfeiture will be determined by straight line interpolation between zero and 30% of the number of Sponsor Shares.

Any Sponsor Shares subject to vesting will become vested if, within three years of the Closing, the closing price of the New Company Common Stock on the NYSE (or other exchange or other market where the New Company Common Stock is then traded) equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30 trading day period, or if there is a change of control of the Company. If neither of these events occur within three years of the Closing, then the unvested Sponsor Shares will be forfeited.

The vesting provisions were analyzed under ASC 480 and ASC 815 and determined equity classification was not precluded and should remain classified as permanent equity until the business combination is consummated.

 

22

Table of Contents

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from January 20, 2021 (inception) through September 30, 2023 were organizational activities and those necessary to prepare for the Initial Public Offering, described below. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the three months ended September 30, 2023, we had a net loss of $1,094,737, which consists of change in fair value of convertible promissory notes related party of $22,210, interest expense on the related party convertible promissory notes of $24,634, and operating costs of $2,652,552 which mainly consists of $1,575,322 in legal fees, $174,008 in consulting services related to the business combination, $146,812 in prepaid insurance amortization and $756,410 in other various expenses, offset by interest earned on marketable securities held in the Trust Account of $1,604,659.

For the three months ended September 30, 2022, we had a net income of $684,286, which consists of interest earned on marketable securities held in the Trust Account of $1,071,188 offset by operating costs of $386,902, which mainly consists of $146,813 in prepaid insurance amortization, $55,774 in legal fees and $181,315 in other various expenses.

For the nine months ended September 30, 2023, we had a net income of $705,617, which consists of interest earned on marketable securities held in the Trust Account of $7,024,163, offset by change in fair value of convertible promissory notes related party of $38,199, interest expense on the related party convertible promissory notes of $41,773, and operating costs of $6,238,574 which mainly consists of $3,234,344 in legal fees, $1,410,342 in consulting services related to the business combination, $440,437 in prepaid insurance amortization and $1,153,451 in other various expenses.

For the nine months ended September 30, 2022, we had a net income of $360,273, which consists of interest earned on marketable securities held in the Trust Account of $1,405,427 offset by Operating costs of $1,045,154, which mainly consists of $415,969 in prepaid insurance amortization, $122,411 in travel expenses related to identifying a target, $239,449 in legal and accounting professional fees and $267,325 in other various expenses.

 

23

Table of Contents

Liquidity and Capital Resources

Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of founder shares and the unsecured promissory note to the Sponsor entered on January 28, 2021, pursuant to which the Company was able to borrow up to an aggregate principal amount of $300,000.

On January 18, 2022, we consummated the Initial Public Offering of 23,000,000 Units, which includes the full exercise by the underwriters of its over-allotment option in the amount of 3,000,000 Units at $10.00 per Unit, generating gross proceeds of $230,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 13,550,000 Private Placement Warrants at a price of $1.00 per Private Placement in a private placement to the Sponsor and the Sponsor Co-Investor, generating gross proceeds of $13,550,000.

Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of Private Placement Warrants, a total of $235,750,000 was placed in the Trust Account. We incurred $23,807,600 in Initial Public Offering related costs, including $4,600,000 of underwriting fees and $754,790 of other offering costs.

In connection with the July 14, 2023 special meeting, shareholders holding an aggregate of 15,105,199 of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately $84.2 million remained in the trust account (based on the redemption amount of $10.66 per share).

As of September 30, 2023, the Company had $157,413 in its operating bank account, $85,132,545 in marketable securities held in the Trust Account, which includes $4,210,835 of interest income, which is a result of $10,423,899 of interest income reduced by $6,213,064 of interest paid to redeeming shareholders and a working capital deficit of $510,271. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

For the nine months ended September 30, 2023, cash used in operating activities was $2,747,659. Net income of $705,617 was affected by interest earned on marketable securities held in the Trust Account of $7,024,163 and changes in related party convertible promissory notes of $38,199. Changes in operating assets and liabilities provided $3,532,688 of cash for operating activities.

For the nine months ended September 30, 2023, net cash provided by investing activities was $161,054,354 as a result of the redemption of ordinary shares.

For the nine months ended September 30, 2023, net cash used in financing activities was $158,752,402 as a result of the drawdowns on the related party convertible promissory notes partially offset by the payment of offering costs of $85,000 and redemption of ordinary shares of $161,041,354, offset by proceeds from convertible note – related party of $2,373,952.

For the nine months ended September 30, 2022, cash used in operating activities was $1,740,944. Net income of $360,273 was affected by interest earned on marketable securities held in the Trust Account of $1,405,427. Changes in operating assets and liabilities used $695,790 of cash for operating activities.

For the nine months ended September 30, 2022, net cash used in investing activities was $235,750,000 as a result of the investment into trust from the funds associated with the initial public offering.

For the nine months ended September 30, 2022, net cash provided by financing activities was $238,298,521 which consisted of $225,400,000 from the proceeds from sale of units, $6,221 from the issuance of Class B ordinary shares, $13,550,000 from the sale of private placement warrants, and $75 as a result of draws on the promissory note partially offset by the payment of offering costs of $417,146 and payment of promissory note of $240,629.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be net of taxes payable and excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant, at the option of the lender. The warrants would be identical to the Private Placement Warrants.

 

24

Table of Contents

We will need to raise additional capital through loans or additional investments from the Sponsor, shareholders, officers, directors, or third parties. Our officers and directors and the Sponsor may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. On January 26, 2023, the Sponsor agreed to lend the Company an aggregate of up to $375,000 for working capital purposes pursuant to a convertible promissory note. On March 29, 2023 Michael M. Andretti, William J. Sandbrook, and William M. Brown agreed to lend the Company an aggregate of up to $500,000, $500,000, and $100,000, respectively, pursuant to individual convertible promissory notes. We had drawn an aggregate of $2,373,952 under the convertible promissory notes as of September 30, 2023, which includes drawdowns of $175,000 on January 26, 2023, $725,555 on March 29, 2023, $225,001 on April 27, 2023, $234,869 on May 19, 2023, $713,527 on June 2, 2023 and $300,000 on August 31, 2023. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about our ability to continue as a going concern one year from the date that these financial statements are issued.

In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB’s”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by April 18, 2024 (or such later date as may be approved by shareholder vote), then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 18, 2024 (or such later date as may be approved by shareholder vote).

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2023. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a sum of up to $15,000 per month for office space and secretarial and administrative services. We began incurring these fees on January 12, 2022 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination or our liquidation.

As of September 30, 2023 and December 31, 2022, the Company had a total of $2,440,000 and $160,000, respectively, of deferred legal fees to be paid to the Company’s legal advisors upon consummation of the Business Combination, which is included in the accompanying balance sheet as of September 30, 2023 and December 31, 2022, respectively.

On December 22, 2022, the Company entered into an engagement letter with KPMG LLP (“KPMG”), pursuant to which KPMG will assist the Company in performing due diligence in connection with the initial Business Combination. The Company paid a $275,000 and $450,554 fee in January 2023 and March 2023, respectively, to KPMG in connection with this arrangement. The fees in connection with the services rendered are expensed as incurred and are payable upon the earlier of the termination of KPMG’s engagement and the closing of the Initial Business Combination. During the three and nine months ended September 30, 2023, the Company paid $0 and $725,554, respective, towards this engagement and no further balance is due.

On January 24, 2023, the Company entered into a letter agreement with Kroll, LLC (“Duff & Phelps”), pursuant to which Duff & Phelps will serve as an independent financial advisor to the Board of the Company and will provide a fairness opinion regarding the initial Business Combination. The Company paid a $50,000 non-refundable retainer fee in January 2023 to Duff & Phelps in connection with this arrangement. The Company has agreed to pay Duff & Phelps an additional (i) $150,000 fee payable upon Duff & Phelps informing the Company that it is prepared to deliver a fairness opinion in connection with the initial Business Combination and (ii) $400,000 fee payable upon closing of the initial Business Combination. As of September 30, 2023, the opinion was delivered as such, the Company paid $224,918. As of September 30, 2023, the Company incurred fees totaling $624,918, of which $400,000 is included in accrued expenses on the Company’s condensed consolidated balance sheets.

On January 24, 2023, the Company entered into an engagement letter with Cassels Brock & Blackwell LLP (“Cassels”), pursuant to which Cassels will represent the Company as Canadian counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023 the Company recorded $177,500 to accounts payable on the condensed consolidated balance sheet.

On February 3, 2023, the Company entered into an engagement letter with Macfarlanes LLP (“Macfarlanes”), pursuant to which Macfarlanes will represent the Company as English law counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023 the Company had paid Macfarlanes $472,526. The Company does not expect to incur any additional costs from this agreement.

 

25

Table of Contents

On April 12, 2023, the Company entered into an engagement letter with KPMG LLP (“KPMG”), pursuant to which KPMG will assist the Company in performing due diligence in connection with a prospective initial Business Combination. The Company paid a total of $459,870 in fees in April and May 2023 to KPMG in connection with this arrangement. In connection with the engagement letter, an additional $919,740 is due and payable upon successful completion of the Business Combination with a specified target company. The fees in connection with the services rendered are expensed as incurred.

On June 12, 2023, the Company entered into a letter agreement with MacKenzie Partners, Inc. (“MacKenzie”), pursuant to which MacKenzie provided advisory, consulting and proxy solicitation services for the Extraordinary General Meeting. The Company agreed to pay MacKenzie a fee of $15,000 plus expenses, payable following the conclusion of the Extraordinary General Meeting. As of September 30, 2023 the Company incurred and paid $26,803 of fees from Mackenzie.

On June 26, 2023, the Company entered into an engagement letter with Bass, Berry & Sims PLC (“Bass, Berry & Sims”), pursuant to which Bass, Berry & Sims will represent the Company as outside counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023, the Company has paid $22,754 and there is no accrued expenses related to this agreement on the condensed consolidated balance sheet. No further fees are expected in connection with this agreement.

On August 28, 2023, the Company entered into an engagement letter with Dentons UK and Middle East LLP (“Dentons”), pursuant to which Dentons will provide legal advising on any filings requirements as a result of the transaction in Spain or the United Kingdom. The fees in connection with the services rendered are expensed as incurred and are due upon the completion of the initial business combination. As of September 30, 2023, the Company has incurred $27,763 in fees which is included in accrued expense on the Company condensed consolidated balance sheets. The Company does expect to incur any additional costs from this agreement.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

On September 25, 2023, the Company received a letter from RBC Capital Markets, LLC waiving their rights to their portion of the deferred underwriting fee subject to the closing of the announced proposed business combination with Zapata Computing.

Critical Accounting Policies

The preparation of condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Class A Ordinary Shares Subject to Possible Redemption

We account for our shares of Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, all of the Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ deficit section of our balance sheets.

Net Income (Loss) Per Ordinary Share

Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. At September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

Warrant Instruments

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own Class A ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

 

26

Table of Contents

Convertible Promissory Notes—Related Party

The Company accounts for its convertible promissory notes under ASC 815, Derivatives and Hedging (“ASC 815”). Under ASC 815-15-25, the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the notes and fair value at each drawdown date are recognized as either an expense in the condensed consolidated statements of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains or losses in the condensed consolidated statements of operations. Changes in the estimated fair value of the notes are recognized as non-cash change in the fair value of the convertible promissory notes in the condensed consolidated statements of operations. The fair value of the option to convert into private warrants was valued utilizing the closed-form model.

Share-Based Compensation

The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations.

Recent Accounting Standards

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed consolidated financial statements.

 

27

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2023, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective. Accordingly, management believes that the unaudited condensed consolidated financial statements included in this Quarterly Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

None

 

28

Table of Contents

Item 1A: Risk Factors

Factors that could cause the Company’s actual business, financial condition and/or results of operations to differ materially from those in this Quarterly Report are any of the risk factors described in our annual report on Form 10-K for the fiscal year ended December 21, 2022 filed with the SEC on March 22, 2023 (the “Annual Report”). Additional information regarding the Company’s business combination with Zapata Computing, Inc., including risk factors regarding the proposed business combination, is included in the registration statement on Form S-4 filed by the Company with the SEC on October 27, 2023. Any of these risk factors could result in a significant or material adverse effect on the Company’s business, financial condition and/or results of operations. Additional risk factors not presently known to the Company or that the Company currently deems immaterial may also impair the Company’s business, financial condition and/or results of operations. As of the date of this report, there have been no material changes to the risk factors disclosed in the Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On January 18, 2022, we consummated the Initial Public Offering of 23,000,000 Units. The Units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $230,000,000. RBC Capital Markets acted as sole book-running manager of the Initial Public Offering. The securities in the offering were registered under the Securities Act on registration statement on Form S-1(No. 333-254627). The Securities and Exchange Commission declared the registration statements effective on January 12, 2022.

Simultaneous with the consummation of the Initial Public Offering, the Sponsor consummated the private placement of an aggregate of 13,550,000 Units at a price of $1.00 per Private Unit, generating total proceeds of $13,550,000. Each Unit consists of one Class A Ordinary Share and one-half of one redeemable public warrant (“Public Warrant”). Each Private Placement Warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The Private Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions.

Of the gross proceeds received from the Initial Public Offering, the exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $235,750,000 was placed in the Trust Account.

We paid a total of $4,600,000 in underwriting discounts and commissions and $754,790 for other costs and expenses related to the Initial Public Offering.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

 

29

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.    Description of Exhibit
2.1    Business Combination Agreement, dated as of September 6, 2023, by and among the Company, Tigre Merger Sub, Inc. and Zapata Computing, Inc. (incorporated by reference to Exhibit 2.1 filed to the registration statement on Form S-4 filed by the Company on October 27, 2023).
3.1    Amendments to the Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.2 filed to the registration statement on Form S-4 filed by the Company on October 27, 2023).
10.1    Form of Stockholder Support Agreement (Individual - Common Stock) (incorporated by reference to Exhibit 10.1 filed to the Current Report on Form 8-K filed by the Company on September 6, 2023).
10.2    Form of Stockholder Support Agreement (Entity - Preferred Stock) (incorporated by reference to Exhibit 10.2 filed to the Current Report on Form 8-K filed by the Company on September 6, 2023).
10.3    Amended and Restated Sponsor Support Agreement (incorporated by reference to Exhibit 10.1 filed to the registration statement on Form S-4 filed by the Company on October 27, 2023).
10.4    Form of Lock-Up Agreement (Common Stockholders) (incorporated by reference to Exhibit 10.4 filed to the Current Report on Form 8-K filed by the Company on September 6, 2023).
10.5    Form of Lock-Up Agreement (Preferred Stockholders) (incorporated by reference to Exhibit 10.5 filed to the Current Report on Form 8-K filed by the Company on September 6, 2023).
10.6    Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.6 filed to the Current Report on Form 8-K filed by the Company on September 6, 2023).
10.7    Form of Non-Redemption Agreement (incorporated by reference to Exhibit 10.1 filed to the Current Report on Form 8-K filed by the Company on July 6, 2023).
31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*    Inline XBRL Instance Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

*

Filed herewith.

 

30

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   ANDRETTI ACQUISITION CORP.
Date: November 6, 2023    By:   

/s/ William J. Sandbrook

   Name:    William J. Sandbrook
   Title:    Co-Chief Executive Officer (Principal Executive Officer)
Date: November 6, 2023    By:   

/s/ William M. Brown

   Name:    William M. Brown
   Title:    President and Chief Financial Officer
      (Principal Financial and Accounting Officer)

 

31

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, William J. Sandbrook, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Andretti Acquisition Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 6, 2023

 

/s/ William J. Sandbrook

William J. Sandbrook

Co-Chief Executive Officer

(Principal Executive Officer)

 

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, William M. Brown, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Andretti Acquisition Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 6, 2023

 

/s/ William M. Brown

William M. Brown

President and Chief Financial Officer

(Principal Financial and Accounting Officer)

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Andretti Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, William J. Sandbrook, Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 6, 2023

 

/s/ William J. Sandbrook

William J. Sandbrook

Co-Chief Executive Officer

(Principal Executive Officer)

 

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Andretti Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, William M. Brown, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 6, 2023

 

/s/ William M. Brown

William M. Brown

President and Chief Financial Officer

(Principal Financial and Accounting Officer)

v3.23.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2023
Nov. 06, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q3  
Entity Registrant Name ANDRETTI ACQUISITION CORP.  
Entity Central Index Key 0001843714  
Entity File Number 001-41218  
Entity Tax Identification Number 98-1578373  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One 7615 Zionsville Road  
Entity Address, City or Town Indianapolis  
Entity Address, State or Province IN  
Entity Address, Postal Zip Code 46268  
City Area Code 317  
Local Phone Number 872-2700  
Trading Symbol WNNR  
Title of 12(b) Security Class A ordinary shares, $0.0001 par value  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable public warrant [Member]    
Document Information [Line Items]    
Trading Symbol WNNR.U  
Title of 12(b) Security Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable public warrant  
Security Exchange Name NYSE  
Public warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share [Member]    
Document Information [Line Items]    
Trading Symbol WNNR WS  
Title of 12(b) Security Public warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share  
Security Exchange Name NYSE  
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   7,894,801
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   5,750,000
v3.23.3
Condensed Colsolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash $ 157,413 $ 616,120
Prepaid expenses and other current assets 199,068 590,883
Total Current Assets 356,481 1,207,003
Prepaid insurance, long-term 0 24,469
Marketable securities held in Trust Account 85,132,545 239,149,736
TOTAL ASSETS 85,489,026 240,381,208
Current liabilities    
Accounts payable and accrued expenses 824,979 30,348
Accrued interest payable – related party 41,773 0
Accrued offering costs 0 85,000
Total Current Liabilities 866,752 115,348
Convertible note—related party 1,653,337 0
Deferred legal fee 2,440,000 160,000
Deferred underwriting fee payable 8,050,000 8,050,000
Total Liabilities 13,010,089 8,325,348
Commitments and Contingencies (see Note 6)
Class A ordinary shares subject to possible redemption; $0.0001 par value; 7,894,801 and 23,000,000 shares issued and outstanding at redemption value of $10.78 and $10.40 per share as of September 30, 2023 and December 31, 2022, respectively 85,132,545 239,149,736
Shareholders' Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (12,654,183) (7,094,451)
Total Shareholders' Deficit (12,653,608) (7,093,876)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT 85,489,026 240,381,208
Common Class A [Member]    
Shareholders' Deficit    
Ordinary Shares 0 0
Common Class B [Member]    
Shareholders' Deficit    
Ordinary Shares $ 575 $ 575
v3.23.3
Condensed Colsolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Temporary equity, redemption price per share $ 10.25  
Preferred stock par or stated value per share $ 0.0001 $ 0.0001
Preferred stock shares authorized 5,000,000 5,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common Class A [Member]    
Temporary equity, par or stated value per share $ 0.0001 $ 0.0001
Temporary equity, shares issued 7,894,801 23,000,000
Temporary equity, shares outstanding 7,894,801 23,000,000
Temporary equity, redemption price per share $ 10.78 $ 10.4
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares authorized 500,000,000 500,000,000
Common stock shares issued 0 0
Common stock shares outstanding 0 0
Common Class B [Member]    
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares authorized 50,000,000 50,000,000
Common stock shares issued 5,750,000 5,750,000
Common stock shares outstanding 5,750,000 5,750,000
v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Formation costs, professional fees and general and administrative costs $ 2,652,552 $ 386,902 $ 6,238,574 $ 1,045,154
Loss from operations (2,652,552) (386,902) (6,238,574) (1,045,154)
Other income:        
Interest earned on marketable securities held in Trust Account 1,604,659 1,071,188 7,024,163 1,405,427
Change in fair value of Convertible Promissory Notes – Related Party (22,210) 0 (38,199) 0
Interest expense – Convertible Promissory Notes – Related Party (24,634) 0 (41,773) 0
Other income, net 1,557,815 1,071,188 6,944,191 1,405,427
Net (loss) income $ (1,094,737) $ 684,286 $ 705,617 $ 360,273
Common Class A [Member]        
Other income:        
Basic weighted average shares outstanding 11,835,288 23,000,000 19,182,202 21,567,766
Diluted weighted average shares outstanding 11,835,288 23,000,000 19,182,202 21,567,766
Basic net (loss) income per share $ (0.06) $ 0.02 $ 0.03 $ 0.01
Diluted net (loss) income per share $ (0.06) $ 0.02 $ 0.03 $ 0.01
Common Class B [Member]        
Other income:        
Basic weighted average shares outstanding 5,750,000 5,750,000 5,750,000 5,703,297
Diluted weighted average shares outstanding 5,750,000 5,750,000 5,750,000 5,703,297
Basic net (loss) income per share $ (0.06) $ 0.02 $ 0.03 $ 0.01
Diluted net (loss) income per share $ (0.06) $ 0.02 $ 0.03 $ 0.01
v3.23.3
Condensed Consolidated Statements of Changes In Shareholders' Deficit - USD ($)
Total
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Common Class B [Member]
Common Stock [Member]
Beginning balance at Dec. 31, 2021 $ 14,139 $ 24,425 $ (10,861) $ 575
Beginning balance, (in shares) at Dec. 31, 2021       5,750,000
Sale of 13,550,000 Private Placement Warrants 13,550,000 13,550,000    
Proceeds allocated to Public Warrants 6,440,000 6,440,000    
Forfeiture of Class B shares by Sponsor for reissuance to Anchor Investor   143   $ (143)
Forfeiture of Class B shares by Sponsor for reissuance to Anchor Investor (in shares)       (1,430,923)
Purchase of Class B shares by Anchor Investor including excess fair value over purchase price 10,409,031 10,408,888   $ 143
Purchase of Class B shares by Anchor Investor including excess fair value over purchase price (in shares)       1,430,923
Value of transaction costs allocated to fair value equity instruments (707,430) (707,430)    
Accretion for Class A ordinary shares to redemption amount (35,290,170) (29,716,026) (5,574,144)  
Net income (loss) (276,453)   (276,453)  
Ending balance at Mar. 31, 2022 (5,860,883) 0 (5,861,458) $ 575
Ending balance, (in shares) at Mar. 31, 2022       5,750,000
Beginning balance at Dec. 31, 2021 14,139 24,425 (10,861) $ 575
Beginning balance, (in shares) at Dec. 31, 2021       5,750,000
Net income (loss) 360,273     $ 75,345
Ending balance at Sep. 30, 2022 (6,629,584) 0 (6,630,159) $ 575
Ending balance, (in shares) at Sep. 30, 2022       5,750,000
Beginning balance at Mar. 31, 2022 (5,860,883) 0 (5,861,458) $ 575
Beginning balance, (in shares) at Mar. 31, 2022       5,750,000
Accretion for Class A ordinary shares to redemption amount (334,239)   (334,239)  
Net income (loss) (47,560)   (47,560)  
Ending balance at Jun. 30, 2022 (6,242,682) 0 (6,243,257) $ 575
Ending balance, (in shares) at Jun. 30, 2022       5,750,000
Accretion for Class A ordinary shares to redemption amount (1,071,188)   (1,071,188)  
Net income (loss) 684,286   684,286 $ 136,857
Ending balance at Sep. 30, 2022 (6,629,584) 0 (6,630,159) $ 575
Ending balance, (in shares) at Sep. 30, 2022       5,750,000
Beginning balance at Dec. 31, 2022 (7,093,876) 0 (7,094,451) $ 575
Beginning balance, (in shares) at Dec. 31, 2022       5,750,000
Proceeds received in excess of fair value of convertible promissory notes 288,221 288,221    
Accretion for Class A ordinary shares to redemption amount (2,537,664) (288,221) (2,249,443)  
Net income (loss) 267,108   267,108  
Ending balance at Mar. 31, 2023 (9,076,211) 0 (9,076,786) $ 575
Ending balance, (in shares) at Mar. 31, 2023       5,750,000
Beginning balance at Dec. 31, 2022 (7,093,876) 0 (7,094,451) $ 575
Beginning balance, (in shares) at Dec. 31, 2022       5,750,000
Net income (loss) 705,617     $ 162,733
Ending balance at Sep. 30, 2023 (12,653,608) 0 (12,654,183) $ 575
Ending balance, (in shares) at Sep. 30, 2023       5,750,000
Beginning balance at Mar. 31, 2023 (9,076,211) 0 (9,076,786) $ 575
Beginning balance, (in shares) at Mar. 31, 2023       5,750,000
Proceeds received in excess of fair value of convertible promissory notes 375,050 375,050    
Accretion for Class A ordinary shares to redemption amount (2,881,840) (375,050) (2,506,790)  
Net income (loss) 1,533,246   1,533,246  
Ending balance at Jun. 30, 2023 (10,049,755) 0 (10,050,330) $ 575
Ending balance, (in shares) at Jun. 30, 2023       5,750,000
Proceeds received in excess of fair value of convertible promissory notes 95,543 95,543    
Accretion for Class A ordinary shares to redemption amount (1,604,659) (95,543) (1,509,116)  
Net income (loss) (1,094,737)   (1,094,737) $ (357,955)
Ending balance at Sep. 30, 2023 $ (12,653,608) $ 0 $ (12,654,183) $ 575
Ending balance, (in shares) at Sep. 30, 2023       5,750,000
v3.23.3
Condensed Consolidated Statements of Changes In Shareholders' Deficit (Parenthetical)
 3 Months Ended
Mar. 31, 2022
shares
Private Placement Warrants [Member]  
Class Of Warrant Or Rights Issued During The Period 13,550,000
v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net income $ 705,617 $ 360,273
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of Convertible Promissory Notes – Related Party 38,199 0
Interest earned on marketable securities held in Trust Account (7,024,163) (1,405,427)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 391,815 (612,572)
Prepaid insurance, long-term 24,469 (171,281)
Deferred legal fee payable 2,280,000 28,000
Accrued interest payable 41,773 0
Accrued expenses 794,631 60,063
Net cash used in operating activities (2,747,659) (1,740,944)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account 0 (235,750,000)
Cash withdrawn from Trust Account in connection with redemption 161,041,354 0
Net cash provided by (used in) investing activities 161,041,354 (235,750,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of Class B ordinary shares to Anchor Investor 0 6,221
Proceeds from sale of Units, net of underwriting discounts paid 0 225,400,000
Proceeds from sale of Private Placement Warrants 0 13,550,000
Proceeds from promissory note – Related Party 0 75
Proceeds from convertible promissory notes— Related Party 2,373,952 0
Repayment of promissory note – Related Party 0 (240,629)
Payment of offering costs (85,000) (417,146)
Redemption of Class A ordinary shares (161,041,354) 0
Net cash (used in) provided by financing activities (158,752,402) 238,298,521
Net Change in Cash (458,707) 807,577
Cash – Beginning of period 616,120 0
Cash – End of period 157,413 807,577
Non-Cash investing and financing activities:    
Accretion for Class A ordinary shares to redemption amount 7,024,163 1,405,427
Proceeds received from convertible promissory notes in excess of initial fair value 758,814 0
Offering costs included in accrued offering costs 0 85,000
Excess fair value of Founder shares attributable to Anchor Investor 0 10,402,810
Remeasurement of Class A ordinary shares to redemption amount 0 35,290,170
Deferred underwriting fee payable $ 0 $ 8,050,000
v3.23.3
Description of Organization And Business Operations
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Organization And Business Operations
NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Andretti Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 20, 2021. The Company was incorporated for the purpose of effecting a merger, consolidation share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). On August 18, 2023, the Company formed Tigre Merger Sub, Inc. a wholly owned subsidiary of the Company.
The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
All activity for the period from January 20, 2021 (inception) through September 30, 2023 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering.
On January 18, 2022, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares” or the “Class A Ordinary Shares”), which includes the full exercise by the underwriters of its over-allotment option in the amount of 3,000,000 Units at $10.00 per Unit, generating gross proceeds of $230,000,000, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 13,550,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Andretti Sponsor LLC (the “Sponsor”) and a third party institutional accredited investor (the “Sponsor
Co-Investor”),
generating gross proceeds of $13,550,000, which is described in Note 4.
Transaction costs amounted to $23,807,600, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees, $10,402,810 for the fair value of the Founder Shares attributable to the Sponsor
Co-Investors
 
(see
Note 5), and $754,790 of other offering costs.
Following the closing of the Initial Public Offering on January 18, 2022, an amount of $235,750,000 ($10.25 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), to be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions
of Rule 2a-7 of the
Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company.
The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.25 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The
per-share
amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights in connection with a Business Combination with respect to the Company’s warrants.
The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement that may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.
The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or
pre-initial
business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.
The Company’s Amended and Restated Memorandum and Articles of Association previously provided that the Company will have (i) the
18-month
period from the closing of the Initial Public Offering in which the Company must complete a Business Combination, (ii) the
21-month
or
24-month,
as applicable, period from the closing of the Initial Public Offering in which the Company must complete a Business Combination if the Sponsor has extended the period of time for the Company to complete a Business Combination by purchasing additional Private Placement Warrants, or (iii) such other extended time period in which the Company must complete a Business Combination pursuant to an amendment to its Amended and Restated Memorandum and Articles of Association(the “Combination Period”). At the special meeting of the Company held on July 14, 2023, shareholders of the Company approved an amendment to the Company’s Amended and Restated Memorandum and Articles of Association to extend the Combination Period to April 18, 2024. However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate of
 
15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$
84.2
 
million remained in the trust account (based on the redemption amount of
 
$
10.66
per share).
The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.25).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.25 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.25 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
 
Risks and Uncertainties
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed consolidated financial statements.
Going Concern Consideration
As of September 30, 2023, we had cash of $157,413 and working capital deficit of $510,271.
Until the consummation of a Business Combination, the Company will be using the funds held outside the Trust Account for identifying and evaluating target businesses, performing due diligence on prospective target businesses, paying for travel expenditures, reviewing corporate documents and material agreements of prospective target businesses, and structuring, negotiating and completing a Business Combination.
The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If the Company is unable to complete the Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued.
In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB’s”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to raise additional funds to alleviate liquidity needs as well as complete a Business Combination by April 18, 2024 (or such later date as may be approved by shareholder vote), then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 18, 2024 (or such later date as may be approved by shareholder vote).
v3.23.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 22, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and Shareholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
 
Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Marketable Securities Held in Trust Account
At September 30, 2023 and December 31, 2022, all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities.
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate of
 
15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$
84.2
 
million remained in the trust account (based on the redemption amount of
 
$
10.66
per share).
Convertible Promissory Notes—Related Party
The Company accounts for its convertible promissory notes under ASC 815, Derivatives and Hedging (“ASC 815”). Under ASC
815-15-25,
the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the notes and fair value at each drawdown date are recognized as either an expense in the condensed consolidated statements of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the condensed consolidated statements of operations. The fair value of the option to convert into private warrants was valued utilizing the closed-form model.
Offering Costs
The Company complies with the requirements of Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. Offering
costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs amounted to $23,807,600, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees, $10,402,810 for the fair value of the Founder Shares attributable to the Sponsor
Co-Investor
 
(see
Note 5), and $754,790 of other offering costs. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to the total proceeds received. Offering costs associated with the Class A ordinary shares were charged against their carrying value and offering costs associated with the warrants were charged to additional
paid-in
capital.
 
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” (“ASC 480”) Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’(deficit) equity. The Company’s Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A Ordinary Shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A Ordinary Shares are affected by charges against additional paid in capital and accumulated deficit.
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
 
The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,500,000 Class A ordinary shares in the aggregate. As of September 30, 2023, the Company had dilutive securities that are Public Warrants that could potentially be exercised into ordinary shares and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented.
 
   
For the Three Months Ended
September 30,
    
For the Nine Months Ended
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
   
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
  
Basic and diluted net (loss) income per ordinary share
                                                                
Numerator:
                                                                
Allocation of net (loss) income, as adjusted
   $ (736,782 )    $ (357,955 )    $ 547,429     $ 136,857     $ 542,884     $ 162,733     $ 284,928     $ 75,345  
Denominator:
                                                                
Basic and diluted weighted average shares outstanding
     11,835,288       5,750,000       23,000,000       5,750,000       19,182,202       5,750,000       21,567,766       5,703,297  
Basic and diluted net (loss) income per ordinary share
   $ (0.06 )    $ (0.06 )    $ 0.02     $ 0.02     $ 0.03     $ 0.03     $ 0.01     $ 0.01  
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. The Company had not experienced losses on this account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed consolidated balance sheets, primarily due to their short-term nature.
Warrant Instruments
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the instruments are outstanding. Upon further review of the warrant agreements, management concluded that the Public Warrants and Private Placement Warrants to be issued pursuant to the warrant agreements qualify for equity accounting treatment.
Share-Based Compensation
The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations.
 
Recent Accounting Standards
In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13–Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.
v3.23.3
Public Offering
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Public Offering
NOTE 3 — PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 23,000,000 Units, which included a full exercise by the underwriter of its over-allotment option in the amount of 3,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A Ordinary Share and
one-half
of one redeemable public warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A Ordinary Share at an exercise price of $11.50 per whole share (see Note 7).
v3.23.3
Private Placement
 9 Months Ended
Sep. 30, 2023
Private Placement [Abstract]  
Private Placement
NOTE 4 — PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor and SOL Verano Blocker 1 LLC, a Delaware limited liability company and a third party institutional accredited investor (the “Sponsor
Co-Investor”),
 
purchased
an aggregate of 13,550,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $13,550,000, in a private placement transaction. Each Private Placement Warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
v3.23.3
Related Party Transactions
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
NOTE 5 — RELATED PARTY TRANSACTIONS
Founder Shares
On January 28, 2021, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 7,187,500 Class B Ordinary Shares (the “Founder Shares”). On March 2, 2021, the Sponsor transferred 30,000 Founder Shares to Cassandra S. Lee for the consideration of $104.35 (approximately $0.003 per share) and 25,000 Founder Shares to each of Zakary C. Brown, James W. Keyes, Gerald D. Putnam and John J. Romanelli, in each case for the consideration of $86.96 (approximately $0.003 per Founder Share), resulting in the Sponsor holding 7,057,500 Founder Shares. On November 17, 2021, the Sponsor surrendered an aggregate of 1,437,500 Founder Shares for no consideration, thereby reducing the aggregate number of Founder Shares held by the Sponsor to 5,620,000 Founder Shares. Immediately prior to the Initial Public Offering, the Sponsor forfeited 1,430,923 Founder Shares in connection with the issuance of Founder Shares to the Sponsor
Co-Investor.
The Company entered into agreements with the Sponsor
Co-Investor,
pursuant to which such Sponsor
Co-Investor
purchased (i) an aggregate of approximately 25% of the issued and outstanding, or 1,430,923 Founder Shares, and (ii) an aggregate of 3,450,000 Private Placement Warrants from the Sponsor immediately prior to the closing of the Initial Public Offering. The Sponsor
Co-Investor
entered into an agreement to vote all of the Founder Shares it owns in favor of an initial Business Combination and will also agree not to redeem any Founder Shares it owns in connection with the completion of the initial Business Combination. The Sponsor
Co-Investor
was not granted any material additional shareholder or other rights, other than the Founder Shares.
Subject to the Sponsor
Co-Investor
purchasing 100% of the Founder Shares allocated to it, in connection with the closing of the Initial Public Offering, the Sponsor sold an aggregate of 1,430,923 Founder Shares to the Sponsor
Co-Investor
at their original purchase price of $.0043 per share. The Company estimated the aggregate fair value of the Founder Shares attributable to the Sponsor
Co-Investor
to be $10,402,810, or $7.27 per share. The excess of the fair value of the Founder Shares was determined to be a contribution to the Company from the founders in accordance with Staff Accounting Bulletin (SAB) Topic 5T and an offering cost in accordance with SAB Topic 5A. Accordingly, the offering costs were recorded against additional paid in capital in accordance with the accounting of other offering costs.
 
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any30-tradingday period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property.
On July 6, 2023, the Company and Sponsor, entered into
non-redemption
agreements (the
“Non-Redemption
Agreements”) with unaffiliated third parties (the “Investors”). Pursuant to the
Non-Redemption
Agreements, the Investors agreed not to redeem an aggregate of 3.5 million Class A ordinary shares of the Company (the
“Non-Redeemed
Shares”) in connection with the Extraordinary General Meeting held. In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to the Investors an aggregate of 875,000 Class B ordinary shares of the Company held by the Sponsor immediately following consummation of an initial business combination if the Investors continue to hold such
Non-Redeemed
Shares through the Extraordinary General Meeting. The transfer of these shares are contingent upon the business combination, as such no expense has been recorded as of September 30, 2023.
Administrative Support Agreement
The Company entered into an agreement commencing on January 12, 2022 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $15,000 per month for office space and administrative and support services. For the three and nine months ended September 30, 2023, the Company incurred and paid $45,000 and $135,000 in fees for these services, respectively. For the three and nine months ended September 30, 2022, the Company incurred and paid $45,000 and $128,710 in fees for these services, respectively.
Promissory Note — Related Party
On January 28, 2021, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On December 17, 2021, the Company and the Sponsor agreed to amend the Promissory Note to increase the aggregate principal amount of the Promissory Note to $400,000 and to change the date by which the Promissory Note was payable. The Promissory Note, as amended, was
non-interest
bearing and payable on the earlier of December 31, 2022 and the completion of the Initial Public Offering. The total outstanding loan of $240,629 was repaid at the time of the Initial Public Offering, on January 18, 2022. Borrowings under the Promissory Note are no longer available.
Convertible Promissory Notes – Related Party
In order to finance transaction costs in connection with a Business Combination, the Company issued unsecured promissory notes (collectively, the “Notes”) to the Sponsor on January 25, 2023, Michael M. Andretti, William J. Sandbrook, and William M. Brown all on March 29, 2023 (collectively, the “Payees”), in the amounts of up to $375,000, $500,000, $500,000, and $100,000, respectively. The proceeds of the Notes, which may be drawn down from time to time until the Company consummates the initial Business Combination, will be used for general working capital purposes. The Notes bear interest of 4.50% per annum and are payable in full upon the earlier to occur of (i) the date on which the Company consummates an initial business combination or (ii) the liquidation date of the Company in accordance with its amended and restated memorandum and articles of association. A failure to pay the principal and accrued interest within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall be deemed an event of default, in which case the Notes may be accelerated. At the election of the Payees, up to $1,500,000 of the principal amounts of the Notes may be converted into private placement warrants of the Company, with such terms as are described in the prospectus included in the registration statement on
FormS-1
(Reg.No. 333-254627)
filed by the Company with the Securities and Exchange Commission and declared effective on January 12, 2022, at a price of $1.00 per warrant. The terms of the Conversion Warrants would be identical to the warrants issued by the Company to the Sponsor in a private placement that was consummated in connection with the Initial Public Offering. The Payees shall be entitled to certain registration rights relating to the Conversion Warrants. The issuance of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. If the Company completes a Business Combination, the Company will repay the Notes out of the proceeds of the Trust Account released to the Company. Otherwise, the Notes will be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Notes, but no proceeds held in the Trust Account will be used to repay the Notes. On May 17, 2023, the notes were amended and restated to increase the total borrowing amounts to $800,000 for Michael M. Andretti, $800,000 for William J. Sandbrook, and $160,000 for William M. Brown. On May 23, 2023, the notes were amended and restated to increase the total borrowing amounts to $1,400,000 for Michael M. Andretti, $1,400,000 for William J. Sandbrook, and $280,000 for William M. Brown. The notes are payable upon the earlier of the liquidation of the Company or the consummation of initial business combination.
At September 30, 2023, there was $2,373,952 of cumulative cash advanced under the Notes. The Notes were valued using the fair value method. The initial advances on the Notes totaling $2,373,952, consisting of draws of $175,000 at January 26, 2023, $725,555 at March 29, 2023, $225,001 at April 27, 2023, $234,869 at May 19, 2023, $713,527 at June 2, 2023 and $300,000 at August 31, 2023 were valued at $119,391 as of January 26, 2023, $492,943 as of March 29, 2023, $153,288 at April 27, 2023, $160,231 at May 19, 2023, $484,828 at June 2, 2023 and $204,457 at August 31, 2023 whereas the collective difference of $758,814 was recorded as a credit to shareholders’ deficit. The change in the fair value of the note recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023, was $22,210 and $38,199, respectively, resulting in a fair value of the Notes of $1,653,337 (see Note 8).
v3.23.3
Commitments And Contingencies
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingencies
NOTE 6 — COMMITMENTS AND CONTINGENCIES
Registration and Shareholders Rights
Pursuant to a registration and shareholder rights agreement entered into on January 12, 2022, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provide that no sales of these securities will be effected until after the expiration of the applicable lockup period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
On September 25, 2023, the Company received a letter from RBC Capital Markets, LLC waiving their rights to the deferred underwriting fee subject to the closing of the announced proposed business combination with Zapata Computing.
Consulting Agreements
On February 16, 2021, the Company entered into a consulting agreement with ICR, LLC (“ICR”), pursuant to which ICR will provide investor and media relations support in connection with the search for a potential Business Combination. The fees in connection with the services rendered are expensed as incurred. In connection with the consulting agreement, a success fee of $250,000 is due and payable solely upon successful completion of a Business Combination.
 
As such, this fee is not reflected on the Company’s condensed consolidated statements of operation or condensed consolidated balance sheets as of September 30, 2023.
On December 22, 2022, the Company entered into an engagement letter with KPMG LLP (“KPMG”), pursuant to which KPMG will assist the Company in performing due diligence in connection with the initial Business Combination. The Company paid a $275,000
and $450,554
fee in January 2023 and March 2023, respectively, to KPMG in connection with this arrangement. The fees in connection with the services rendered are expensed as incurred and are payable upon the earlier of the termination of KPMG’s engagement and the closing of the Initial Business Combination. During the three and nine months ended September 30, 2023, the Company paid $0 and
$725,554
, respective, towards this engagement and no further balance is due.
On January 24, 2023, the Company entered into a letter agreement with Kroll, LLC (“Duff & Phelps”), pursuant to which Duff & Phelps will serve as an independent financial advisor to the Board of the Company and will provide a fairness opinion regarding the initial Business Combination. The Company paid a $50,000
non-refundable
retainer fee in January 2023 to Duff & Phelps in connection with this arrangement. The Company has agreed to pay Duff & Phelps an additional (i) $150,000 fee payable upon Duff & Phelps informing the Company that it is prepared to deliver a fairness opinion in connection with the initial Business Combination and (ii) $400,000 fee payable upon closing of the initial Business Combination. As of September 30, 2023, the opinion was delivered as such, the Company paid $224,918. As of September 30, 2023, the Company incurred fees totaling $624,918, of which $400,000 is included in accrued expenses on the Company’s condensed consolidated balance sheets.
On January 24, 2023, the Company entered into an engagement letter with Cassels Brock & Blackwell LLP (“Cassels”), pursuant to which Cassels will represent the Company as Canadian counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023 the Company recorded $177,500 to accounts payable on the condensed consolidated balance sheet.
On February 3, 2023, the Company entered into an engagement letter with Macfarlanes LLP (“Macfarlanes”), pursuant to which Macfarlanes will represent the Company as English law counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023 the Company had paid Macfarlanes $472,526. The Company does not expect to incur any additional costs from this agreement.
On April 12, 2023, the Company entered into an engagement letter with KPMG LLP (“KPMG”), pursuant to which KPMG will assist the Company in performing due diligence in connection with a prospective initial Business Combination. The Company paid a total of $459,870 in fees in April and May 2023 to KPMG in connection with this arrangement. In connection with the engagement letter, an additional $919,740 is due and payable upon successful completion of the Business Combination with a specified target company. The fees in connection with the services rendered are expensed as incurred.
On June 12, 2023, the Company entered into a letter agreement with MacKenzie Partners, Inc. (“MacKenzie”), pursuant to which MacKenzie provided advisory, consulting and proxy solicitation services for the Extraordinary General Meeting. The Company agreed to pay MacKenzie a fee of $15,000 plus expenses, payable following the conclusion of the Extraordinary General Meeting. As of September 30, 2023 the Company incurred
and paid
$26,803 of fees
to
 
Mackenzie
.
On June 26, 2023, the Company entered into an engagement letter with Bass, Berry & Sims PLC (“Bass, Berry & Sims”), pursuant to which Bass, Berry & Sims will represent the Company as outside counsel in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. As of September 30, 2023, the Company has paid $22,754 and there
are
 no accrued expenses related to this agreement on the condensed consolidated balance sheet. No further fees are expected in connection with this agreement.
On August 28, 2023, the Company entered into an engagement letter with Dentons UK and Middle East LLP (“Dentons”), pursuant to which Dentons will provide legal advising on any filings requirements as a result of the transaction in Spain or the United Kingdom. The fees in connection with the services rendered are expensed as incurred and are due upon the completion of the initial business combination. As of September 30, 2023, the Company has incurred $27,763
 in fees which
are
 included in accrued expenses on the Company’s condensed consolidated balance sheets
. The Company does expect to incur any additional costs from this agreement.
 
Legal Fees
As of September 30, 2023 and December 31, 2022, the Company had a total of $2,440,000 and $160,000, respectively, of deferred legal fees to be paid to the Company’s legal advisors upon consummation of the Business Combination, which
are
 included in the accompanying condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, respectively.
Engagement Letter
On July 4, 2023, the Company entered into an engagement letter with Cohen & Company Capital Markets (“Cohen”), pursuant to which Cohen will act as capital markets advisor to the Company in connection with the initial Business Combination. The Company agreed to pay Cohen a fee of (i) $500,000 in cash payable upon the closing of the initial Business Combination, plus (ii) $1,000,000 in either cash or post-Business Combination equity, payable 180 days after the closing of the initial Business Combination plus (iii) $1,000,000 payable in either cash or post-Business Combination equity, payable 270 calendar days following the initial Business Combination.
On July 5, 2023, the Company entered into an engagement letter with Kroll Associates, Inc. (“Kroll”), pursuant to which Kroll will provide due diligence services in connection with the initial Business Combination. The fees in connection with the services rendered are expensed as incurred. The Company agreed to pay Kroll a retainer of $10,000, which was paid upon execution of the engagement
letter.
Non-Redemption
Agreements
On July 6, 2023, the Company and Sponsor, entered into
non-redemption
agreements (the
“Non-Redemption
Agreements”) with unaffiliated third parties (the “Investors”). Pursuant to the
Non-Redemption
Agreements, the Investors agreed not to redeem an aggregate of 3.5 million Class A ordinary shares of the Company (the
“Non-Redeemed
Shares”) in connection with the Extraordinary General Meeting held. In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to the Investors an aggregate of 875,000 Class 
B ordinary shares of the Company held by the Sponsor immediately following consummation of an initial business combination if the investors continue to hold such Non-Redeemed Shares through the Extraordinary General Meeting. As a result of the transfer of the shares only occurring at the consummation of an initial business combination, no expense has been recorded as of September 30, 2023. Upon the consummation of the initial business combination, the Company will record an expense which is representative of a capital contribution from the Sponsor.
On July 14, 2023, the Company held an extraordinary general meeting of the Company’s shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved amendments (the “Articles Amendment”) to the Articles to (i) extend the date by which the Company must consummate its initial business combination from July 18, 2023 to April 18, 2024, or such earlier date as determined by the Company’s board of directors in its sole and absolute discretion (the “Extension”), and (ii) eliminate the limitation that the Company shall not redeem its Class A ordinary shares included as part of the units sold in the Company’s initial public offering (such shares, including any shares issued in exchange thereof, the “public shares”) that was consummated on January 18, 2022 (the “IPO”) to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation”).
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate
of 15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$84.2 
million remained in the trust account (based on the redemption amount
 
of
$10.66 per share).
Business Combination Agreement
On September 6, 2023, Andretti Acquisition Corp., a Cayman Islands exempted company incorporated with limited liability, entered into a Business Combination Agreement (as it may be amended and/or restated from time to time, the “Business Combination Agreement”) with Tigre Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”) and Zapata Computing, Inc., a Delaware corporation (“Zapata”).
Merger Consideration
At the effective time of the Merger:
 
  (i)
each share of Zapata’s preferred stock, par value $0.0001 per share (the “Zapata Preferred Stock”) will be converted into the right to receive a number of newly issued shares of New Parent Common Stock equal to the Per Share Preferred Stock Consideration (as defined in the Business Combination Agreement) in accordance with the terms of the Business Combination Agreement;
 
  (ii)
each share of Zapata’s common stock, par value of $0.0001 (the “Zapata Common Stock”) will be converted into the right to receive a number of newly issued shares of New Parent Common Stock equal to the Per Share Common Stock Consideration (as defined in the Business Combination Agreement) in accordance with the terms of the Business Combination Agreement; and
 
  (iii)
each option to purchase shares of Zapata’s common stock, whether or not exercisable and whether or not vested (each, a “Zapata Option”) will automatically be converted into an option to purchase, on the same terms and conditions as were applicable to such Zapata Option immediately prior to the Effective Time, including applicable vesting conditions, a number of shares of New Parent Common Stock determined in accordance with the terms of the Business Combination Agreement.
The aggregate value of the consideration that the holders of Zapata’s securities collectively shall be entitled to receive from Company in connection with the Business Combination shall not exceed $200,000,000 (calculated with each share of New Parent Common Stock deemed to have a value of $10 per share).
Other Agreements in Connection with the Business Combination Agreement:
Sponsor Support Agreement
Concurrently with the execution of the Business Combination Agreement, SPAC, the Sponsor, and certain key equityholders of the Sponsor entered into a certain Sponsor Support Agreement, which amended and restated in its entirety that certain letter, dated January 12, 2022, by and among such parties. Pursuant to the Sponsor Support Agreement, those certain equityholders who are parties thereto agreed to: (a) vote all shares of the SPAC Common Stock beneficially owned by them (including any additional shares of SPAC Common Stock over which they acquire ownership or the power to vote) in favor of the Merger and all other transactions contemplated by the Business Combination Agreement; (b) the continued lock-up of the founder shares held by such persons for the earlier of (i) one (1) year or (ii) the date on which the post-Closing share price equals or exceeds $12 for twenty (20) trading days in a thirty (30)-trading day period commencing at least one hundred and fifty (150) days after the Closing (or in the event of a liquidation, merger or other similar event); and (c) the continued lock-up of the private placement warrants until thirty (30) days following Closing.
Additionally, the Sponsor Support Agreement provides that the Sponsor Shares are subject to certain vesting and forfeiture conditions based on: (a) the total dollar amount of cash or cash equivalents available in the Trust Account after any redemptions plus (b) the total amount of financing raised by both SPAC and Zapata (including any bridge financing raised by Zapata prior to the Closing Date) to be consummated prior to the consummation of the Merger (all such amounts, the “Closing Available Cash”) as follows:
 
 
•
 
If the Closing Available Cash is an amount equal to $25 million or more, then all Sponsor Shares will be fully vested;
 
 
•
 
If the Closing Available Cash is $10 million or less, then 30% of the Sponsor Shares will be unvested and subject to forfeiture; and
 
 
•
 
If the Closing Available Cash is more than $10 million but less than $25 million then the number of Sponsor Shares that will be unvested and subject to forfeiture will be determined by straight line interpolation between zero and 30% of the number of Sponsor Shares.
Any Sponsor Shares subject to vesting will become vested if, within three years of the Closing, the closing price of the New Company Common Stock on the NYSE (or other exchange or other market where the New Company Common Stock is then traded) equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30 trading day period, or if there is a change of control of the Company. If neither of these events occur within three years of the Closing, then the unvested Sponsor Shares will be forfeited.
The vesting provisions were analyzed under ASC 480 and ASC 815 and determined equity classification was not precluded and should remain classified as permanent equity until the business combination is consummated.
v3.23.3
Shareholders' Equity (Deficit)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Shareholders' Equity (Deficit)
NOTE 7 — SHAREHOLDERS’ DEFICIT
Preference Shares
— The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
— The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there are 7,894,801 and 23,000,000 Class A Ordinary Shares subject to possible redemption and presented as temporary equity, respectively.
Class
 B Ordinary Shares
— The Company is authorized to issue 50,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 5,750,000 Class B ordinary shares issued and outstanding.
Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A Ordinary Shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. In connection with a Business Combination, the Company may enter into a shareholder’s agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other governance arrangements that differ from those in effect upon completion of the Initial Public Offering.
The Class B ordinary shares will automatically convert into Class A Ordinary Shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A Ordinary Shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, deemed issued, or to be issued, to any seller of an interest in the target to the Company in a Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A Ordinary Shares at a rate of less than
one-to-one.
Warrants
– As of September 30, 2023 and December 31, 2022 there are 11,500,000 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of Class A Ordinary Shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary Shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A Ordinary Share upon exercise of a warrant unless the Class A Ordinary Share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
While the Company has registered the Class A Ordinary Shares issuable upon exercise of the Public Warrants under the Securities Act as part of the registration statement of which this prospectus forms a part, the Company does not plan on keeping a prospectus current until required to pursuant to the public warrant agreement. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which this prospectus forms a part or a new registration statement for the registration, under the Securities Act, of the Class A Ordinary Shares issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the closing a Business Combination and to maintain the effectiveness of such post-effective amendment or registration statement and a current prospectus relating thereto until the expiration or redemption of the Public Warrants in accordance with the provisions of the public warrant agreement. If such post-effective amendment or registration statement covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants is not effective by the 60th business day after the closing of a Business Combination, holders of the Public Warrants may, until such time as there is an effective post-effective amendment or registration statement and during any other period when the Company will have failed to maintain an effective registration statement, exercise Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A Ordinary Shares are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their
 
Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Class A Ordinary Shares issuable upon exercise of the Public Warrants and (y) use its commercially reasonable efforts to register or qualify for sale the Class A Ordinary Shares issuable upon exercise of the warrants under the blue sky laws to the extent an exemption is not available.
Redemption of Public Warrants. Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per Public Warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption to each Public Warrant holder; and
 
  •  
if, and only if, the last reported sale price of the Class A Ordinary Shares has been at least $18.00 per share (subject to adjustment in compliance with the public warrant agreement) for any ten trading days within the20-trading-dayperiod ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Public Warrants.
The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the30-dayredemption period or the Company elected to require the exercise of the Public Warrants on a “cashless basis” as described below. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the Public Warrants for that number of Class A Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Ordinary Shares underlying the Public Warrants, multiplied by the excess of the “fair market value” (as defined below) of the Class A Ordinary Shares over the exercise price of the Public Warrants by (y) the “fair market value.” Solely for purposes of this paragraph, the “fair market value” means the volume-weighted average last reported sale price of the Class A Ordinary Shares as reported for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the Public Warrants. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below their exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or holders of the Class B ordinary shares or their respective affiliates, without taking into account any Founder Shares held by the Sponsor, holders of the Class B ordinary shares or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume-weighted average trading price of its Class A Ordinary Shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
As of September 30, 2023 and December 31, 2022 there are 13,550,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are
non-redeemable.
The warrant agreements contain a provision wherein warrant holders can receive an “alternative issuance” (as defined in the applicable warrant agreement), including as a result of a tender offer that constitutes a change of control.
v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
NOTE 8. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820 for its financial assets and liabilities that
are re-measured
and reported at fair value at each reporting period, and
non-financial
assets and liabilities that
are re-measured
and reported at fair value at least annually.
 
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3:    Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
   
Level
     
September 30, 2023
     
December 31, 2022
  
Assets:
                           
Marketable securities held in Trust Account
      1      $ 85,132,545      $ 239,149,736  
Liabilities:
                           
Convertible promissory notes – related party
      3        1,653,337        –  
The estimated fair value of the convertible promissory notes was based on the following significant inputs:
 
    
September 30,
2023
  
Risk-free interest rate
      4.60 % 
Time to Expiration (in years)
      5.42  
Expected volatility
      8.1 % 
Exercise price
    $ 11.50  
Dividend yield
      0.00 % 
Share Price
    $ 10.75  
Probability of transaction
      70.00 % 
The following table presents the changes in the fair value of the Level 3 convertible promissory notes:
 
Fair value as of January 1, 2023
    $ —   
Borrowings
      900,555  
Proceeds received in excess of initial fair value of convertible promissory notes
      (288,221 ) 
Change in fair value
      608  
    
 
 
  
Fair value as of March 31, 2023
      612,942  
Borrowings
      1,173,397  
Proceeds received in excess of initial fair value of convertible promissory notes
      (375,050 ) 
Change in fair value
      15,381  
    
 
 
  
Fair value as of June 30, 2023
      1,426,670  
Borrowings
      300,000  
Proceeds received in excess of initial fair value of convertible promissory notes
      (95,543 ) 
Change in fair value
      22,210  
    
 
 
  
Fair value as of September 30, 2023
    $ 1,653,337  
    
 
 
  
There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September 30, 2023 for the convertible promissory notes.
v3.23.3
Subsequent Events
 9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events
NOTE 9 – SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date
that
the unaudited condensed consolidated financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events, that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.
On October 27, 2023, the Company filed the Form
S-4
registration statement in connection with the business combination with Zapata Computing, Inc. Additional information regarding the Company’s business combination with Zapata Computing, Inc., including risk factors regarding the proposed business combination, is included in the registration statement on Form S-4 filed by the Company with the SEC on October 27, 2023.
On November 1, 2023, the Company was advanced $300,000 on the Notes. The cumulative cash advanced under the Notes as of this filing was $2,673,952.
v3.23.3
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 22, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and Shareholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
 
Principles of Consolidation
Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Marketable Securities Held in Trust Account
Marketable Securities Held in Trust Account
At September 30, 2023 and December 31, 2022, all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities.
In connection with the July 14, 2023 special meeting, shareholders holding an aggregate of
 
15,105,199
of the Company’s Class A ordinary shares exercised their right to redeem their shares prior to the redemption deadline on July 12, 2023. Following the withdrawals from the trust account in connection with such redemptions, approximately
$
84.2
 
million remained in the trust account (based on the redemption amount of
 
$
10.66
per share).
Convertible Promissory Notes—Related Party
Convertible Promissory Notes—Related Party
The Company accounts for its convertible promissory notes under ASC 815, Derivatives and Hedging (“ASC 815”). Under ASC
815-15-25,
the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the notes and fair value at each drawdown date are recognized as either an expense in the condensed consolidated statements of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as
non-cash
gains or losses in the condensed consolidated statements of operations. The fair value of the option to convert into private warrants was valued utilizing the closed-form model.
Offering Costs
Offering Costs
The Company complies with the requirements of Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. Offering
costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs amounted to $23,807,600, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees, $10,402,810 for the fair value of the Founder Shares attributable to the Sponsor
Co-Investor
 
(see
Note 5), and $754,790 of other offering costs. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to the total proceeds received. Offering costs associated with the Class A ordinary shares were charged against their carrying value and offering costs associated with the warrants were charged to additional
paid-in
capital.
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” (“ASC 480”) Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’(deficit) equity. The Company’s Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A Ordinary Shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A Ordinary Shares are affected by charges against additional paid in capital and accumulated deficit.
Income Taxes
Income Taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income (Loss) Per Ordinary Share
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
 
The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 11,500,000 Class A ordinary shares in the aggregate. As of September 30, 2023, the Company had dilutive securities that are Public Warrants that could potentially be exercised into ordinary shares and then share in the earnings of the Company. The warrants are not exercisable until 30 days after the completion of a Business Combination. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented.
 
   
For the Three Months Ended
September 30,
    
For the Nine Months Ended
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
   
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
  
Basic and diluted net (loss) income per ordinary share
                                                                
Numerator:
                                                                
Allocation of net (loss) income, as adjusted
   $ (736,782 )    $ (357,955 )    $ 547,429     $ 136,857     $ 542,884     $ 162,733     $ 284,928     $ 75,345  
Denominator:
                                                                
Basic and diluted weighted average shares outstanding
     11,835,288       5,750,000       23,000,000       5,750,000       19,182,202       5,750,000       21,567,766       5,703,297  
Basic and diluted net (loss) income per ordinary share
   $ (0.06 )    $ (0.06 )    $ 0.02     $ 0.02     $ 0.03     $ 0.03     $ 0.01     $ 0.01  
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. The Company had not experienced losses on this account.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed consolidated balance sheets, primarily due to their short-term nature.
Warrant Instruments
Warrant Instruments
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the instruments are outstanding. Upon further review of the warrant agreements, management concluded that the Public Warrants and Private Placement Warrants to be issued pursuant to the warrant agreements qualify for equity accounting treatment.
Share-Based Compensation
Share-Based Compensation
The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations.
Recent Accounting Standards
Recent Accounting Standards
In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13–Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.
v3.23.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share
   
For the Three Months Ended
September 30,
    
For the Nine Months Ended
September 30,
  
   
2023
    
2022
    
2023
    
2022
  
   
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
    
Class A
    
Class B
  
Basic and diluted net (loss) income per ordinary share
                                                                
Numerator:
                                                                
Allocation of net (loss) income, as adjusted
   $ (736,782 )    $ (357,955 )    $ 547,429     $ 136,857     $ 542,884     $ 162,733     $ 284,928     $ 75,345  
Denominator:
                                                                
Basic and diluted weighted average shares outstanding
     11,835,288       5,750,000       23,000,000       5,750,000       19,182,202       5,750,000       21,567,766       5,703,297  
Basic and diluted net (loss) income per ordinary share
   $ (0.06 )    $ (0.06 )    $ 0.02     $ 0.02     $ 0.03     $ 0.03     $ 0.01     $ 0.01  
v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Assets Measured at Fair Value On a Recurring Basis
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
   
Level
     
September 30, 2023
     
December 31, 2022
  
Assets:
                           
Marketable securities held in Trust Account
      1      $ 85,132,545      $ 239,149,736  
Liabilities:
                           
Convertible promissory notes – related party
      3        1,653,337        –  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
The estimated fair value of the convertible promissory notes was based on the following significant inputs:
 
    
September 30,
2023
  
Risk-free interest rate
      4.60 % 
Time to Expiration (in years)
      5.42  
Expected volatility
      8.1 % 
Exercise price
    $ 11.50  
Dividend yield
      0.00 % 
Share Price
    $ 10.75  
Probability of transaction
      70.00 % 
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following table presents the changes in the fair value of the Level 3 convertible promissory notes:
 
Fair value as of January 1, 2023
    $ —   
Borrowings
      900,555  
Proceeds received in excess of initial fair value of convertible promissory notes
      (288,221 ) 
Change in fair value
      608  
    
 
 
  
Fair value as of March 31, 2023
      612,942  
Borrowings
      1,173,397  
Proceeds received in excess of initial fair value of convertible promissory notes
      (375,050 ) 
Change in fair value
      15,381  
    
 
 
  
Fair value as of June 30, 2023
      1,426,670  
Borrowings
      300,000  
Proceeds received in excess of initial fair value of convertible promissory notes
      (95,543 ) 
Change in fair value
      22,210  
    
 
 
  
Fair value as of September 30, 2023
    $ 1,653,337  
    
 
 
  
v3.23.3
Description of Organization And Business Operations - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Jul. 14, 2023
Jan. 18, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Date of incorporation       Jan. 20, 2021    
Proceeds from issuance initial public offering       $ 0 $ 225,400,000  
Proceeds from sale of private placement warrants       0 13,550,000  
Deferred underwriting fee payable       0 8,050,000  
Fair value of founder shares in excess attributable to anchor investor       0 10,402,810  
Payments to acquire restricted investments       $ 0 $ 235,750,000  
Temporary equity, redemption price per share       $ 10.25    
Banking regulation, mortgage banking, net worth, minimum $ 5,000,001     $ 5,000,001    
Percentage of public shares that can be transferred without any restriction       15.00%    
Percentage of public shares to be redeemed in case business combination is not consummated       100.00%    
Period from the closing of the initial public offering within which business combination shall be completed       18 months    
Number of days within which the public shares shall be redeemed       10 days    
Expenses payable on dissolution       $ 100,000    
Net asset value per share       $ 10.25    
Cash       $ 157,413   $ 616,120
Working Capital       510,271    
Number of stock bought back by the entity at the redemption price 15,105,199          
Marketable securities held in Trust Account $ 84,200,000     $ 85,132,545   $ 239,149,736
Stock redemption price per share $ 10.66          
Maximum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Period from the closing of the initial public offering within which business combination shall be completed, extended term       24 months    
Minimum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Prospective assets of acquire as a percentage of fair value of assets in the trust account       80.00%    
Period from the closing of the initial public offering within which business combination shall be completed, extended term       21 months    
Minimum [Member] | Business Combination [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Equity method investment, ownership percentage       50.00%    
Private Placement Warrants [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Class of warrant or rights issued during the period     13,550,000      
IPO [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Deferred offering costs       $ 23,807,600    
Underwriting fees       4,600,000    
Deferred underwriting fee payable       8,050,000    
Fair value of founder shares in excess attributable to anchor investor       10,402,810    
Other offering costs       $ 754,790    
Payments to acquire restricted investments   $ 235,750,000        
Sale of stock, price per share   $ 10.25        
Term of restricted investments   185 days        
Private Placement [Member] | Private Placement Warrants [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Class of warrant or rights issued during the period       13,550,000    
Class of warrants or rights issue price per share       $ 1    
Proceeds from sale of private placement warrants       $ 13,550,000    
Public Shares [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Share price       $ 10.25    
Public Shares [Member] | Share Price Less Than Ten Point Twenty Five [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Share price       $ 10.25    
Public Shares [Member] | IPO [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares, new issues   23,000,000        
Proceeds from issuance initial public offering   $ 230,000,000        
Public Shares [Member] | Over-Allotment Option [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares, new issues   3,000,000        
Shares issued, price per share   $ 10        
v3.23.3
Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:                
Allocation of net (loss) income, as adjusted $ (1,094,737) $ 1,533,246 $ 267,108 $ 684,286 $ (47,560) $ (276,453) $ 705,617 $ 360,273
Common Class A [Member]                
Denominator:                
Basic weighted average shares outstanding 11,835,288     23,000,000     19,182,202 21,567,766
Diluted weighted average shares outstanding 11,835,288     23,000,000     19,182,202 21,567,766
Basic net (loss) income per ordinary share $ (0.06)     $ 0.02     $ 0.03 $ 0.01
Diluted net (loss) income per ordinary share $ (0.06)     $ 0.02     $ 0.03 $ 0.01
Common Class A [Member] | Common Stock [Member]                
Numerator:                
Allocation of net (loss) income, as adjusted $ (736,782)     $ 547,429     $ 542,884 $ 284,928
Common Class B [Member]                
Denominator:                
Basic weighted average shares outstanding 5,750,000     5,750,000     5,750,000 5,703,297
Diluted weighted average shares outstanding 5,750,000     5,750,000     5,750,000 5,703,297
Basic net (loss) income per ordinary share $ (0.06)     $ 0.02     $ 0.03 $ 0.01
Diluted net (loss) income per ordinary share $ (0.06)     $ 0.02     $ 0.03 $ 0.01
Common Class B [Member] | Common Stock [Member]                
Numerator:                
Allocation of net (loss) income, as adjusted $ (357,955)     $ 136,857     $ 162,733 $ 75,345
v3.23.3
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 9 Months Ended
Jul. 14, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash and cash equivalents   $ 0   $ 0
Unrecognized tax benefits   0   0
Unrecognized tax benefits, Income tax penalties and interest accrued   0   0
Tax provision   0    
Cash, FDIC insured amount   250,000    
Deferred under writing fees payable   0 $ 8,050,000  
Fair value of founder shares in excess attributable to anchor investor   $ 0 $ 10,402,810  
Period to exercise warrants after business combination   30 days    
Number of stock bought back by the entity at the redemption price 15,105,199      
Marketable securities held in Trust Account $ 84,200,000 $ 85,132,545   $ 239,149,736
Stock redemption price per share $ 10.66      
IPO [Member]        
Deferred offering costs   23,807,600    
Underwriting Fees   4,600,000    
Deferred under writing fees payable   8,050,000    
Fair value of founder shares in excess attributable to anchor investor   10,402,810    
Other offering costs   $ 754,790    
Common Class A [Member]        
Class of warrant or right, Number of securities called by warrants or rights   11,500,000    
v3.23.3
Public Offering - Additional Information (Detail) - Common Class A [Member]
Jan. 18, 2022
$ / shares
shares
Public Warrant [Member]  
Class of warrant or right, number of securities called by each warrant or right 1
Class of warrant or right, exercise price of warrants or rights | $ / shares $ 11.5
IPO [Member]  
Stock issued during period, Shares 23,000,000
Shares issued, price per share | $ / shares $ 10
Common stock, conversion basis Each Unit consists of one Class A Ordinary Share and one-half of one redeemable public warrant (“Public Warrant”).
Over-Allotment Option [Member]  
Stock issued during period, Shares 3,000,000
v3.23.3
Private Placement - Additional Information (Detail) - USD ($)
 3 Months Ended
Jan. 18, 2022
Mar. 31, 2022
Proceeds from issuance of warrants   $ 6,440,000
Common Class A [Member] | Private Placement Warrants [Member]    
Class of warrant or right, exercise price of warrants or rights $ 11.5  
Common Class A [Member] | Private Placement [Member]    
Class of warrant or right, number of securities called by each warrant or right 1  
The Sponsor And Sponsor Co Investor [Member] | Private Placement [Member] | Private Placement Warrants [Member]    
Class of warrant or right warrants issued during period warrants 13,550,000  
Class of warrant or right warrants issued during period price per warrant $ 1  
Proceeds from issuance of warrants $ 13,550,000  
v3.23.3
Related Party Transactions - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 31, 2023
Jul. 06, 2023
Jun. 02, 2023
May 19, 2023
Apr. 27, 2023
Mar. 29, 2023
Jan. 26, 2023
Jan. 18, 2022
Jan. 12, 2022
Nov. 17, 2021
Mar. 02, 2021
Jan. 28, 2021
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
May 23, 2023
May 17, 2023
Jan. 25, 2023
Dec. 31, 2022
Dec. 17, 2021
Related Party Transaction [Line Items]                                              
Repayment of related party debt               $ 240,629                 $ 0 $ 240,629          
Cummulative cash advanced                         $ 2,373,952       2,373,952            
Proceeds Received In Excess Of Fair Value Of Convertible Promissory Notes                         95,543 $ 375,050 $ 288,221                
Convertible Promissory Notes [Member]                                              
Related Party Transaction [Line Items]                                              
Fair value of liability issues $ 300,000   $ 713,527 $ 234,869 $ 225,001 $ 725,555 $ 175,000                   2,373,952            
Notes Payable, Fair Value Disclosure $ 204,457   $ 484,828 $ 160,231 $ 153,288 492,943 $ 119,391           1,653,337       1,653,337         $ 0  
Proceeds Received In Excess Of Fair Value Of Convertible Promissory Notes                                 758,814            
Change In Fair Value Of Convertible Promissory Notes Related Party                         22,210       38,199            
Fair value of notes                         $ 1,653,337       $ 1,653,337            
Non Redemption Agreements [Member] | Unaffiliated Third Parties [Member]                                              
Related Party Transaction [Line Items]                                              
Common stock shares outstanding   3,500,000                                          
Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Stock issued during the period value for services                       $ 25,000                      
Common stock shares outstanding                         5,750,000       5,750,000         5,750,000  
Common Class B [Member] | Non Redemption Agreements [Member]                                              
Related Party Transaction [Line Items]                                              
Shares transferred by sponsor   875,000                                          
Sponsor [Member] | Unsecured Promissory Note Issued To Related Party [Member]                                              
Related Party Transaction [Line Items]                                              
Debt instrument face value                                         $ 375,000    
Debt instrument conversion price per share                 $ 1                            
Debt instrument interest rate                                         4.50%    
Sponsor [Member] | Unsecured Promissory Note Issued To Related Party [Member] | Private Placement Warrants [Member]                                              
Related Party Transaction [Line Items]                                              
Debt instrument convertible into warrants                         $ 1,500,000       $ 1,500,000            
Sponsor [Member] | Unsecured Promissory Note Issued To Related Party [Member] | Amendement To The Promissory Note [Member]                                              
Related Party Transaction [Line Items]                                              
Debt instrument face value                       $ 300,000                     $ 400,000
Sponsor [Member] | Administrative Support Agreement [Member]                                              
Related Party Transaction [Line Items]                                              
Related party transaction expenses payable per month                 $ 15,000       $ 45,000       $ 135,000            
Related party transaction selling general and administrative expenses                               $ 45,000   $ 128,710          
Sponsor [Member] | Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Stock issued during the period shares for services                       7,187,500                      
Common stock shares outstanding                   5,620,000 7,057,500                        
Share based compensation stock shares forfeited during the period                   1,437,500                          
Sponsor [Member] | Common Class B [Member] | Condition For The Transfer Of Founder Shares Before The Lock In Period [Member]                                              
Related Party Transaction [Line Items]                                              
Lock in period of shares one                                 1 year            
Share price                         $ 12       $ 12            
Number of trading days for determining the share price                                 20 days            
Lock in period for shares two                                 150 days            
Sponsor [Member] | Common Class B [Member] | Sponsor Co Investor [Member]                                              
Related Party Transaction [Line Items]                                              
Stock issued during the period shares for services                                 1,430,923            
Inter se transfer of shares value per share                         $ 43       $ 43            
Percentage of outstanding shares                         25.00%       25.00%            
Class of warrants or rights issued during the period units                                 3,450,000            
Maximum percentage of shares issued to related party that may be transferred inter se                         100.00%       100.00%            
Equity fair value                         $ 10,402,810       $ 10,402,810            
Fair value per share                         $ 7.27       $ 7.27            
Michael M. Andretti [Member] | Unsecured Promissory Note Issued To Related Party [Member]                                              
Related Party Transaction [Line Items]                                              
Debt instrument face value           500,000                         $ 1,400,000 $ 800,000      
William J. Sandbrook [Member] | Unsecured Promissory Note Issued To Related Party [Member]                                              
Related Party Transaction [Line Items]                                              
Debt instrument face value           500,000                         1,400,000 800,000      
William M. Brown [Member] | Unsecured Promissory Note Issued To Related Party [Member]                                              
Related Party Transaction [Line Items]                                              
Debt instrument face value           $ 100,000                         $ 280,000 $ 160,000      
Cassandra S Lee [Member] | Sponsor [Member] | Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Inter se transfer of shares                     30,000                        
Inter se transfer of shares value                     $ 104.35                        
Inter se transfer of shares value per share                     $ 0.003                        
Zakary C Brown [Member] | Sponsor [Member] | Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Inter se transfer of shares                     25,000                        
Inter se transfer of shares value                     $ 86.96                        
Inter se transfer of shares value per share                     $ 0.003                        
James W Keyes [Member] | Sponsor [Member] | Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Inter se transfer of shares                     25,000                        
Inter se transfer of shares value                     $ 86.96                        
Inter se transfer of shares value per share                     $ 0.003                        
Gerald D Putnam [Member] | Sponsor [Member] | Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Inter se transfer of shares                     25,000                        
Inter se transfer of shares value                     $ 86.96                        
Inter se transfer of shares value per share                     $ 0.003                        
Johan J Romanelli [Member] | Sponsor [Member] | Common Class B [Member]                                              
Related Party Transaction [Line Items]                                              
Inter se transfer of shares                     25,000                        
Inter se transfer of shares value                     $ 86.96                        
Inter se transfer of shares value per share                     $ 0.003                        
v3.23.3
Commitments And Contingencies - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 06, 2023
Aug. 28, 2023
Jul. 14, 2023
Jul. 06, 2023
Sep. 30, 2023
Sep. 30, 2023
Jul. 05, 2023
Jul. 04, 2023
Jun. 12, 2023
Apr. 12, 2023
Mar. 31, 2023
Jan. 31, 2023
Jan. 24, 2023
Dec. 31, 2022
Nov. 17, 2021
Mar. 02, 2021
Other Commitments [Line Items]                                
Deferred underwriting commission payable current         $ 8,050,000 $ 8,050,000                    
Deferred underwriting commission payable per share         $ 0.35 $ 0.35                    
Deferred legal fee         $ 2,440,000 $ 2,440,000               $ 160,000    
Banking regulation, mortgage banking, net worth, minimum     $ 5,000,001   5,000,001 5,000,001                    
Number of stock bought back by the entity at the redemption price     15,105,199                          
Marketable securities held in trust account     $ 84,200,000   $ 85,132,545 $ 85,132,545               $ 239,149,736    
Stock redemption price per share     $ 10.66                          
Preferred stock par or stated value per share         $ 0.0001 $ 0.0001               $ 0.0001    
Sponsor Shares [Member]                                
Other Commitments [Line Items]                                
Percentage of shares will be unvested and subject to forfeiture         30.00% 30.00%                    
Amount Of Cash Available Equal To Twenty Five Million Or More [Member] | Sponsor Shares [Member]                                
Other Commitments [Line Items]                                
Closing available cash         $ 25,000,000 $ 25,000,000                    
Amount Of Cash Available Equal To Ten Million Or Less [Member] | Sponsor Shares [Member]                                
Other Commitments [Line Items]                                
Closing available cash         10,000,000 10,000,000                    
Amount Of Cash Available More Than Ten Million But Less Than Twenty Five Million [Member] | Sponsor Shares [Member] | Minimum [Member]                                
Other Commitments [Line Items]                                
Closing available cash         10,000,000 10,000,000                    
Amount Of Cash Available More Than Ten Million But Less Than Twenty Five Million [Member] | Sponsor Shares [Member] | Maximum [Member]                                
Other Commitments [Line Items]                                
Closing available cash         $ 25,000,000 $ 25,000,000                    
Sponsor [Member] | Sponsor Shares [Member]                                
Other Commitments [Line Items]                                
Number of trading days for determining the share price           20 days                    
Number of consecutive trading days for determining the share price           30 days                    
Share Price Equal Or Exceeds Twelve Rupees Per Dollar [Member] | Sponsor [Member] | Sponsor Shares [Member]                                
Other Commitments [Line Items]                                
Share price         $ 12 $ 12                    
Common Class B [Member]                                
Other Commitments [Line Items]                                
Common stock shares outstanding         5,750,000 5,750,000               5,750,000    
Common stock par or stated value per share         $ 0.0001 $ 0.0001               $ 0.0001    
Common Class B [Member] | Sponsor [Member]                                
Other Commitments [Line Items]                                
Common stock shares outstanding                             5,620,000 7,057,500
Closing of the Initial Business Combination [Member] | Capital Markets Advisor Fee [Member]                                
Other Commitments [Line Items]                                
Other commitment               $ 500,000                
Post Business Combination Event [Member] | Capital Markets Advisor Fee [Member]                                
Other Commitments [Line Items]                                
Other commitment               1,000,000                
Post Initial Business Combination [Member] | Capital Markets Advisor Fee [Member]                                
Other Commitments [Line Items]                                
Other commitment               $ 1,000,000                
Dentons [Member]                                
Other Commitments [Line Items]                                
Legal fees   $ 27,763                            
Kroll Associates, Inc [Member] | Due Diligence Services [Member]                                
Other Commitments [Line Items]                                
Other commitment             $ 10,000                  
KPMG LLP [Member]                                
Other Commitments [Line Items]                                
Business acquisition cost                   $ 459,870 $ 450,554 $ 275,000        
Accrued professional fees                   $ 919,740            
Payment for professional fees         $ 0 $ 725,554                    
Duff And Phelps [Member]                                
Other Commitments [Line Items]                                
Estimated Fees Payable         400,000 400,000             $ 150,000      
Non refundable retainer fee                       $ 50,000        
Litigation settlement, expense           624,918                    
Payment of litigation expenses         224,918 224,918                    
Duff And Phelps [Member] | Accrued Liabilities [Member]                                
Other Commitments [Line Items]                                
Accrued professional fees         400,000 400,000                    
Cassels Brock And Blackwell LLP [Member]                                
Other Commitments [Line Items]                                
Accrued professional fees         177,500 177,500                    
Macfarlanes LLP [Member]                                
Other Commitments [Line Items]                                
Agreegate professional fees paid         472,526 472,526                    
MacKenzie Partners, Inc [Member]                                
Other Commitments [Line Items]                                
Professional fees commitment                 $ 15,000              
Litigation settlement, expense           26,803                    
Bass, Berry Sims PLC [Member]                                
Other Commitments [Line Items]                                
Agreegate professional fees paid         22,754 22,754                    
Zapata Computing, Inc [Member]                                
Other Commitments [Line Items]                                
Common stock par or stated value per share $ 0.0001                              
Preferred stock par or stated value per share $ 0.0001                              
Purchase price of expected business acquisition $ 200,000,000                              
Business acquisition, share price $ 10                              
Consulting Services Agreement [Member]                                
Other Commitments [Line Items]                                
Success fee payable upon the consummation of business combination         $ 250,000 $ 250,000                    
Non Redemption Agreements [Member] | Common Class B [Member]                                
Other Commitments [Line Items]                                
Shares transferred by sponsor       875,000                        
Non Redemption Agreements [Member] | Unaffiliated Third Parties [Member]                                
Other Commitments [Line Items]                                
Common stock shares outstanding       3,500,000                        
Business Combination Agreement [Member] | SPAC Common Stock [Member] | Sponsor [Member]                                
Other Commitments [Line Items]                                
Number of trading days for determining the share price           20 days                    
Number of consecutive trading days for determining the share price           30 days                    
Number of waiting days after which the share trading days are considered           150 days                    
Business Combination Agreement [Member] | SPAC Common Stock [Member] | Share Price Equal Or Exceeds Twelve Rupees Per Dollar [Member] | Sponsor [Member]                                
Other Commitments [Line Items]                                
Share price         $ 12 $ 12                    
v3.23.3
Shareholders' Equity (Deficit) - Additional Information (Detail)
 9 Months Ended
Sep. 30, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Class of Stock [Line Items]    
Preferred stock shares authorized 5,000,000 5,000,000
Preferred stock shares outstanding 0 0
Preferred stock shares issued 0 0
Preferred stock par or stated value per share | $ / shares $ 0.0001 $ 0.0001
Public Warrants [Member]    
Class of Stock [Line Items]    
Class of warrant or right, outstanding 11,500,000 11,500,000
Class of warrants or rights period after which the warrants or rights are exercisable 30 days  
Class of warrants or rights period of expiry 5 years  
Period within which amendment to the registration statement shall be filed from the date of consummation of business combination 20 days  
Period within which amendment to the registration statement shall be effective from the date of consummation of business combination 60 days  
Class of warrants or rights redemption price per unit | $ / shares $ 0.01  
Class of warrants or rights minimum notice period to be given to warrant holders before redemption 30 days  
Number of trading days for determining the share price 10 days  
Public Warrants [Member] | Event Triggering The Redemption Of Public Warrants [Member]    
Class of Stock [Line Items]    
Share price | $ / shares $ 18  
Number of trading days for determining the share price 10 days  
Number of consecutive trading days for determining the share price 20 days  
Public Warrants [Member] | Event Triggering The Excerciee Price Of Warrants [Member]    
Class of Stock [Line Items]    
Share price | $ / shares $ 18  
Shares issued, price per share | $ / shares $ 9.2  
Percentage of proceeds used or to be used for the consummation of business combination 60.00%  
Number of trading days for determining the volume weighted average price of shares 20 days  
Volume weighted average price of shares | $ / shares $ 9.2  
Exercise price of warrants as a percentage of market value of shares 115.00%  
Exercise price of warrants as a percentage of issue price of shares 115.00%  
Share redemption trigger price as a percentage of market value of shares 180.00%  
Share redemption trigger price as a percentage of issue price of shares 180.00%  
Private Warrants [Member]    
Class of Stock [Line Items]    
Class of warrant or right, outstanding 13,550,000 13,550,000
Class of warrants or rights lock in period 30 days  
Common Class A [Member]    
Class of Stock [Line Items]    
Common stock par or stated value per share | $ / shares $ 0.0001 $ 0.0001
Common stock shares authorized 500,000,000 500,000,000
Common stock shares issued 0 0
Common stock shares outstanding 0 0
Temporary equity, shares outstanding 7,894,801 23,000,000
Common stock shares number of votes per share 1  
Common Class A [Member] | Founder [Member] | Maximum [Member]    
Class of Stock [Line Items]    
Percentage of shares outstanding on conversion from one class to another 20.00%  
Common Class B [Member]    
Class of Stock [Line Items]    
Common stock par or stated value per share | $ / shares $ 0.0001 $ 0.0001
Common stock shares authorized 50,000,000 50,000,000
Common stock shares issued 5,750,000 5,750,000
Common stock shares outstanding 5,750,000 5,750,000
Common stock shares number of votes per share 1  
v3.23.3
Fair Value Measurements - Summary of Assets Measured at Fair Value On a Recurring Basis (Detail) - USD ($)
Sep. 30, 2023
Aug. 31, 2023
Jun. 02, 2023
May 19, 2023
Apr. 27, 2023
Mar. 29, 2023
Jan. 26, 2023
Dec. 31, 2022
Convertible Promissory Notes [Member]                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Liabilities $ 1,653,337 $ 204,457 $ 484,828 $ 160,231 $ 153,288 $ 492,943 $ 119,391 $ 0
Marketable Securities Held in Trust Account [Member]                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Assets $ 85,132,545             $ 239,149,736
v3.23.3
Fair Value Measurements - Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail) - Convertible Promissory Notes [Member]
Sep. 30, 2023
yr
Year / pure
Measurement Input, Risk Free Interest Rate [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 4.6
Measurement Input, Expected Term [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 5.42
Measurement Input, Option Volatility [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 8.1
Measurement Input, Exercise Price [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 11.5
Measurement Input, Expected Dividend Rate [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 0
Measurement Input, Share Price [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 10.75
Measurement Input Probability [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 70
v3.23.3
Fair Value Measurements - Fair Value Net Derivative Asset Liability Measured On Recurring Basis Un 0observable Input Reconciliation (Detail) - Convertible Promissory Notes [Member] - USD ($)
 3 Months Ended 9 Months Ended
Aug. 31, 2023
Jun. 02, 2023
May 19, 2023
Apr. 27, 2023
Mar. 29, 2023
Jan. 26, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                    
Borrowings $ 300,000 $ 713,527 $ 234,869 $ 225,001 $ 725,555 $ 175,000       $ 2,373,952
Ending Balance             $ 1,653,337     1,653,337
Fair Value, Inputs, Level 3 [Member]                    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                    
Beginning Balance             1,426,670 $ 612,942 $ 0 0
Borrowings             300,000 1,173,397 900,555  
Proceeds received in excess of initial fair value of convertible promissory notes             (95,543) (375,050) (288,221)  
Change in fair value             22,210 15,381 608  
Ending Balance             $ 1,653,337 $ 1,426,670 $ 612,942 $ 1,653,337
v3.23.3
Fair Value Measurements - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Fair Value, Inputs, Level 3 [Member] | Convertible Promissory Notes [Member]    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Transfers in or out from other levels $ 0 $ 0
v3.23.3
Subsequent Events - Additional Information (Detail) - Subsequent Event [Member]
Nov. 01, 2023
USD ($)
Subsequent Event [Line Items]  
Debt instrument face value $ 300,000
Notes payable $ 2,673,952
Andretti Acquisition (NYSE:WNNR)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Andretti Acquisition.
Andretti Acquisition (NYSE:WNNR)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Andretti Acquisition.